( (TITLE (S (NP-SBJ (NP (NN Deletion)) (PP (IN at) (NP (NNP ITPR1)))) (VP (VBZ Underlies) (NP (NP (NP (NN Ataxia)) (PP-LOC (IN in) (NP (NNS Mice)))) (CC and) (NP (NP (JJ Spinocerebellar) (NN Ataxia) (CD 15)) (PP-LOC (IN in) (NP (NNS Humans)))))))) )
( (HEADING (NP (NN Abstract))) )
( (S (NP-SBJ (PRP We)) (VP (VBD observed) (NP (DT a) (JJ severe) (JJ autosomal) (JJ recessive) (NN movement) (NN disorder)) (PP-LOC (IN in) (NP (NP (NNS mice)) (VP (VBN used) (NP (-NONE- *)) (PP-LOC (IN within) (NP (PRP$ our) (NN laboratory))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD pursued) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NNS experiments)))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (VP (TO to) (VP (VB define) (NP (NP (DT the) (JJ genetic) (NN lesion)) (VP (VBG underlying) (NP (DT this) (NN disorder)))))) (CC and) (VP (TO to) (VP (VB identify) (NP (DT a) (JJ cognate) (NN disease)) (PP-LOC (IN in) (NP (NP (NNS humans)) (PP (IN with) (NP (NP (NN mutation)) (PP-LOC (IN at) (NP (DT the) (JJ same) (NN locus)))))))))))) (. .)) )
( (S (PP-MNR (IN Through) (NP (NML (NN linkage) (CC and) (NN sequence)) (NN analysis))) (NP-SBJ (PRP we)) (VP (VBP show) (ADVP (RB here)) (SBAR (IN that) (S (NP-SBJ-1 (DT this) (NN disorder)) (VP (VBZ is) (VP (VBN caused) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT a) (JJ homozygous) (NML (PP (IN in) (HYPH -) (NP (NN frame)))) (NML (CD 18) (HYPH -) (NN bp)) (NN deletion)) (PP-LOC (IN in) (NP (NN Itpr1) (PRN (-LRB- -LRB-) (NP (NN Itpr1) (NN Δ18) (HYPH /) (NN Δ18)) (-RRB- -RRB-))))) (, ,) (VP (VBG encoding) (NP (NN inositol) (NML (NML (CD 1) (, ,) (CD 4) (, ,) (CD 5)) (HYPH -) (NN triphosphate)) (NN receptor) (CD 1)))))))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (ADJP (RB previously) (VBN reported)) (JJ spontaneous) (NN Itpr1) (NN mutation)) (PP-LOC (IN in) (NP (NNS mice)))) (VP (VBZ causes) (NP (NP (DT a) (NN phenotype)) (ADJP (JJ identical) (PP (IN to) (NP (NP (DT that)) (VP (VBN observed) (NP (-NONE- *)) (ADVP (RB here)))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT both) (NNS models))) (NP-SBJ (NP (NML (IN in) (HYPH -) (NN frame)) (NN deletion)) (PP-LOC (IN within) (NP (NN Itpr1)))) (VP (VBZ leads) (PP (IN to) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (ADJP (RB normally) (JJ high)) (NN level)) (PP (IN of) (NP (NP (NN Itpr1) (NN expression)) (PP-LOC (IN in) (NP (JJ cerebellar) (NNP Purkinje) (NNS cells)))))))))) (. .)) )
( (S (S (NP-SBJ (NP (NP (JJ Spinocerebellar) (NN ataxia) (CD 15)) (-LRB- -LRB-) (NP (NN SCA15))) (-RRB- -RRB-) (, ,) (NP (DT a) (JJ human) (JJ autosomal) (JJ dominant) (NN disorder))) (, ,) (VP (VBZ maps) (PP (IN to) (NP (NP (DT the) (JJ genomic) (NN region)) (VP (VBG containing) (NP (NN ITPR1))))))) (: ;) (S (ADVP (RB however)) (, ,) (PP-TMP (IN to) (NP (NN date))) (NP-SBJ-1 (DT no) (JJ causal) (NNS mutations)) (VP (VBD had) (VP (VBN been) (VP (VBN identified) (NP-1 (-NONE- *)))))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ (NN ataxia)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ prominent) (NN feature)) (PP-LOC (IN in) (NP (NN Itpr1) (NN mutant) (NNS mice))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD performed) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NNS experiments)))) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB test) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP-SBJ (NP (NN mutation)) (PP (IN at) (NP (NN ITPR1)))) (VP (MD may) (VP (VB be) (NP-PRD (NP (DT the) (NN cause)) (PP (IN of) (NP (NN SCA15))))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP show) (ADVP (RB here)) (SBAR (IN that) (S (NP-SBJ (NP (JJ heterozygous) (NN deletion)) (PP (IN of) (NP (NP (NP (DT the) (NML (CD 5) (SYM ′)) (NN part)) (PP (IN of) (NP (DT the) (NN ITPR1) (NN gene)))) (, ,) (VP (VBG encompassing) (NP (NNS exons) (NML (NML (NML (CD 1)) (PP (SYM –) (NP (CD 10)))) (, ,) (NML (NML (CD 1)) (PP (SYM –) (NP (CD 40)))) (, ,) (CC and) (NML (NML (CD 1)) (PP (SYM –) (NP (CD 44)))))) (PP (IN in) (NP (CD three) (VBN studied) (NNS families))))))) (, ,) (VP (VBZ underlies) (NP (NN SCA15)) (PP-LOC (IN in) (NP (NNS humans))))))) (. .)) )
( (HEADING (NP (NN Author) (NN Summary))) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN identified) (NP (NP (NP (DT a) (JJ spontaneous) (NML (PP (IN in) (HYPH -) (NP (NN frame)))) (NN deletion) (NN mutation)) (PP-LOC (IN in) (NP (DT the) (NN gene) (NN Itpr1)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ causes) (NP (DT a) (JJ recessive) (NN movement) (NN disorder)) (PP-LOC (IN in) (NP (NNS mice))))))))) (. .)) )
( (S (PP (IN In) (NP (DT an) (NN attempt) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB define) (SBAR (IN whether) (S (NP-SBJ (DT any) (JJ similar) (NN disease)) (VP (VBZ occurs) (PP-LOC (IN in) (NP (NNS humans))))))))))) (NP-SBJ (PRP we)) (VP (VBD performed) (NP (NP (DT a) (NN literature) (NN search)) (PP (IN for) (NP (NP (NNS diseases)) (VP (VBN linked) (NP (-NONE- *)) (PP (IN to) (NP (NP (DT the) (JJ human) (JJ chromosomal) (NN region)) (VP (VBG containing) (NP (NN ITPR1)))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD identified) (NP (NP (DT the) (NN disease)) (NP (JJ spinocerebellar) (NN ataxia) (CD 15))) (PP (IN as) (ADJP (VBN linked) (PP (IN to) (NP (DT this) (NN region)))))) (. .)) )
( (S (NP-SBJ (NP (NML (JJ High) (HYPH -) (NN density)) (JJ genomic) (NN analysis)) (PP (IN of) (NP (NP (VBN affected) (NNS members)) (PP (IN from) (NP (CD three) (NNS families)))))) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ-1 (NP (NN disease)) (PP-LOC (IN in) (NP (DT these) (NNS patients)))) (VP (VBD was) (VP (VBN caused) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NN deletion)) (PP (IN of) (NP (NP (DT a) (JJ large) (NN portion)) (PP (IN of) (NP (NP (DT the) (NN region)) (VP (VBG containing) (NP (NN ITPR1)))))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP show) (ADVP (RB here)) (SBAR (IN that) (S (NP-SBJ (DT this) (NN mutation)) (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (JJ dramatic) (NN reduction)) (PP (IN in) (NP (NN ITPR1))))) (PP-LOC (IN in) (NP (NP (NNS cells)) (PP (IN from) (NP (DT these) (NNS patients))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP show) (ADVP (RB convincingly)) (SBAR (IN that) (S (NP-SBJ (NN ITPR1) (NN deletion)) (VP (VBZ underlies) (NP (JJ spinocerebellar) (NN ataxia) (CD 15)) (PP-LOC (IN in) (NP (NNS humans))))))) (. .)) )
( (HEADING (NP (NN Introduction))) )
( (S (NP-SBJ (NP (NP (DT The) (NN use)) (PP (IN of) (NP (JJ forward) (NN genetics)))) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB define) (NP (NP (JJ novel) (NNS loci)) (PP (IN of) (NP (NN interest))) (PP (IN in) (NP (JJ human) (NN disease)))))))) (VP (VBZ has) (VP (VBN become) (ADJP-PRD (RB increasingly) (JJ viable)) (PP (IN with) (NP (NP (DT the) (NN implementation)) (PP (IN of) (NP (NML (JJ large) (HYPH -) (NN scale)) (NN mutagenesis) (NNS programs))))))) (. .)) )
( (S (PP-TMP (RB Prior) (PP (IN to) (NP (DT these) (NNS initiatives)))) (NP-SBJ-1 (DT this) (NN work)) (VP (VBD was) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP (IN in) (ADJP (JJ part))) (PP-MNR (IN by) (NP (NP (DT the) (NN investigation)) (PP (IN of) (NP (NP (JJ spontaneous) (NNS mutations)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP cause) (NP (NNS disorders)) (PP-LOC (IN in) (NP (NN mouse) (NN breeding) (NNS colonies)))))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Careful) (NN observation)) (PP (IN of) (NP (DT these) (JJ serendipitous) (NNS events)))) (VP (VBZ has) (VP (VBN led) (PP (IN to) (NP (NP (DT the) (NML (NN establishment) (CC and) (NN study))) (PP (IN of) (NP (JJ many) (ADJP (FW in) (FW vivo)) (NN disease) (NNS models))))) (PRN (-LRB- [) (NP (CD 3)) (-RRB- ])))) (. .)) )
( (S (PP-TMP (IN During) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (NP (DT a) (NN knockout) (NN line)) (PP (IN of) (NP (NNS mice))))))) (NP-SBJ (PRP we)) (VP (VBD noted) (NP (NP (DT an) (JJ early) (NN movement) (NN disorder)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (VP (VBN inherited) (NP-1 (-NONE- *)) (ADVP (RB independently) (PP (IN of) (NP (NML (VBG targeting) (NN vector)) (NN transmission)))))))))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBD embarked) (PP (IN on) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NNS experiments))))) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (VP (TO to) (VP (VB identify) (NP (NP (DT the) (JJ genetic) (NN lesion)) (VP (VBG underlying) (NP (DT this) (NN movement) (NN disorder)))))) (CC and) (VP (TO to) (VP (VB identify) (NP (NP (DT a) (JJ cognate) (NN disease)) (CC and) (NP (VBG corresponding) (NN mutation))) (PP-LOC (IN in) (NP (NNS humans)))))))) (. .)) )
( (S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP describe) (NP (NP (DT this) (NN effort)) (CC and) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (NP (NN deletion)) (PP-LOC (IN at) (NP (DT the) (NN ITPR1) (NN locus))))))) (PP (IN as) (NP (NP (DT a) (NN cause)) (PP (PP (IN of) (NP (NP (DT this) (NN disorder)) (PP-LOC (IN in) (NP (NNS mice))))) (CC and) (PP (IN of) (NP (NP (NP (JJ spinocerebellar) (NN ataxia) (CD 15)) (-LRB- -LRB-) (NP (NN SCA15))) (-RRB- -RRB-) (PP-LOC (IN in) (NP (NNS humans))))))))) (. .)) )
( (HEADING (NP (NNS Results) (HYPH /) (NN Discussion))) )
( (S (PP-TMP (IN During) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (NP (DT a) (NN line)) (PP (IN of) (NP (NP (NNS mice)) (PP (IN with) (NP (NP (NN knockout)) (PP (IN of) (NP (NP (DT the) (NN gene)) (NP (NN Park7)))))))))))) (NP-SBJ (PRP we)) (VP (VBD noted) (NP (NP (DT an) (JJ early) (NN movement) (NN disorder)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (VP (VBN inherited) (NP-1 (-NONE- *)) (ADVP (RB independently) (PP (IN of) (NP (NML (NN targeting) (NN vector)) (NN transmission)))))))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (JJ initial) (NNS observations)) (VP (VBD suggested) (SBAR (-NONE- *0*) (S (NP-SBJ (DT the) (VBN affected) (NNS mice)) (VP (VBD suffered) (PP (IN from) (NP (NP (DT an) (ADJP (RB apparently) (JJ paroxysmal)) (NN movement) (NN disorder)) (, ,) (VP (ADVP (RB often)) (VBN induced) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NN touch)))))))))) (. .)) )
( (S (S (NP-SBJ (DT The) (JJ abnormal) (NNS movements)) (VP (VBD occurred) (ADVP (RB predominantly)) (PP-LOC (IN below) (NP (DT the) (JJ cervical) (NN level))))) (, ,) (CC and) (S (NP-SBJ-1 (DT the) (NN disorder)) (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ progressive))))) (. .)) )
( (S (PP-TMP (IN At) (NP (JJ initial) (NN examination))) (, ,) (NP-SBJ (DT a) (NML (JJ human) (NN movement) (NN disorder)) (NN specialist) (PRN (-LRB- -LRB-) (NP (NNP K.) (NNP G.) (HYPH -) (NNP H.)) (-RRB- -RRB-))) (VP (VP (VBD likened) (NP (DT the) (NN disorder)) (PP (IN to) (NP (NP (JJ episodic) (JJ intermittent) (NN ataxia)) (CC or) (NP (JJ kinesiogenic) (JJ paroxysmal) (NN dystonia))))) (CC and) (VP (VBD predicted) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (DT an) (NN ion) (NN channel) (NN mutation))) (PP (IN in) (NP (DT the) (NN etiology)))))) (. .)) )
( (S (S (NP-SBJ (VBN Affected) (NNS mice)) (VP (VBD presented) (PP-TMP (IN at) (NP (RB approximately) (JJ postnatal) (NN day) (CD 14))))) (, ,) (CC and) (S (NP-SBJ (NP (NN survival) (NN time)) (PP (IN without) (NP (NN weaning)))) (VP (VBD was) (PP (IN on) (ADJP (JJ average))) (PP-TMP-PRD (NP-ADV (CD 4) (NN wk)) (IN after) (NP (NN onset))))) (. .)) )
( (S (NP-SBJ (NN Breeding) (NNS experiments)) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ-1 (DT the) (VBN observed) (NN disorder)) (VP (VBD was) (VP (VBN inherited) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (DT an) (JJ autosomal) (JJ recessive) (NN manner)))))))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB map) (NP (NP (DT the) (NN location)) (PP (IN of) (NP (DT the) (ADJP (NN disease) (HYPH -) (VBG causing)) (NN lesion))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD performed) (NP (ADJP (NN genome) (HYPH -) (JJ wide)) (NN linkage) (NN analysis)) (S-MNR (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG using) (NP (ADJP (NN strain) (HYPH -) (JJ specific)) (NML (NML (NML (JJ single) (NN nucleotide)) (NNS polymorphisms)) (-LRB- -LRB-) (NML (NNS SNPs)))) (-RRB- -RRB-) (PP-LOC (IN at) (NP (CD 120) (NNS loci))) (PP (IN across) (NP (DT the) (NN mouse) (NN genome)))))) (. .)) )
( (S (NP-SBJ (NP (NN Analysis)) (PP (IN of) (NP (DT these) (NNS data)))) (VP (VBD showed) (NP (NP (DT a) (JJ single) (JJ genomic) (NN region)) (PP (IN with) (NP (NP (JJ significant) (NN linkage)) (PP (IN to) (NP (NN disease)))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG providing) (NP (NP (DT a) (NML (CD two) (HYPH -) (NN point)) (NN LOD) (NN score)) (PP (IN of) (NP (CD 5.13))) (PP-LOC (IN at) (NP (NP (NN marker) (NN 20.MMHAP85FLG2)) (PP-LOC (IN on) (NP (NN Chromosome) (NN 6qE1))))))))) (. .)) )
( (S (NP-SBJ (DT The) (VBN linked) (NN haplotype)) (VP (VBD suggested) (SBAR (-NONE- *0*) (S (NP-SBJ (DT the) (NN mutation)) (VP (VBD had) (VP (VBN occurred) (PP (IN on) (NP (DT the) (NML (NN 129x1) (HYPH /) (NN SvJ)) (NN background))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S1)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NN Literature) (NNS searches)) (VP (VBD revealed) (SBAR (IN that) (S (PP (IN among) (NP (NP (NN disease) (NNS lines)) (VP (VBN mapped) (NP (-NONE- *)) (PP (IN to) (NP (NN 6qE1)))))) (, ,) (NP-SBJ (NP (DT the) (JJ spontaneous) (NN mutant)) (NP (NN opt) (NN mouse))) (VP (VBZ displays) (NP (NP (DT a) (ADJP (RB strikingly) (JJ similar)) (NN presentation)) (PP (IN to) (NP (NP (DT that)) (VP (VBN described) (NP (-NONE- *)) (ADVP (RB here))))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (DT The) (VBG underlying) (JJ genetic) (NN lesion)) (VP (VBG causing) (NP (DT the) (NN opt) (NN phenotype)))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ homozygous) (NML (IN in) (HYPH -) (NN frame)) (NN deletion)) (PP (IN of) (NP (NP (NP (NNS exons) (NML (CD 43) (CC and) (CD 44))) (PP (IN of) (NP (DT the) (NN gene) (NN Itpr1) (PRN (-LRB- -LRB-) (NP (NN Itpr1opt) (HYPH /) (NN opt)) (-RRB- -RRB-))))) (, ,) (VP (VBG encoding) (NP (NN inositol) (NML (NML (CD 1) (, ,) (CD 4) (, ,) (CD 5)) (HYPH -) (NN triphosphate)) (NN receptor) (CD 1) (PRN (-LRB- -LRB-) (NP (NN Itpr1)) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ (NP (NN Sequencing)) (PP (IN of) (NP (NP (NP (DT all) (NNS exons)) (CC and) (NP (NP (NML (NN intron) (HYPH –) (NN exon)) (NNS boundaries)) (PP (IN of) (NP (NN Itpr1))))) (PP-LOC (IN in) (NP (NP (VBN affected) (NNS mice)) (PP (IN from) (NP (DT the) (JJ current) (NN study)))))))) (VP (VBD revealed) (NP (NP (NP (DT a) (JJ single) (NN mutation)) (PP-LOC (IN within) (NP (NN Itpr1)))) (: :) (NP (NP (DT a) (JJ novel) (NML (PP (IN in) (HYPH -) (NP (NN frame)))) (NN deletion)) (PP (IN of) (NP (CD 18) (NN bp))) (PP-LOC (IN within) (NP (NN exon) (CD 36))) (PRN (-LRB- -LRB-) (NP (NN Itpr1Δ18) (HYPH /) (NN Δ18)) (-RRB- -RRB-))))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB confirm) (NP (NP (DT the) (NN pathogenicity)) (PP (IN of) (NP (DT this) (NN mutation))))))) (NP-SBJ-1 (PRP we)) (VP (VBD crossed) (NP (NP (JJ heterozygous) (NNS mice)) (PP (IN from) (NP (DT the) (JJ current) (NN study)) (PRN (-LRB- -LRB-) (NP (NN Itpr1wt) (HYPH /) (NN Δ18)) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NNS mice)) (ADJP (JJ heterozygous) (PP (IN for) (NP (DT the) (NN opt) (NN mutation)))) (PRN (-LRB- -LRB-) (NP (NN Itpr1wt) (HYPH /) (NN opt)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBD resulted) (PP (IN in) (NP (NP (CD two) (NNS litters)) (PP (IN of) (NP (NNS mice))) (PP (IN with) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD four) (VBN affected) (NML (NN Itpr1opt) (HYPH /) (NN Δ18)) (NNS pups))) (-LRB- -LRB-) (PP (IN from) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 15))))) (-RRB- -RRB-) (PP (IN with) (NP (NP (DT a) (NN phenotype)) (ADJP (JJ indistinguishable) (PP (IN from) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (NML (NML (NN Itpr1Δ18) (HYPH /) (NN Δ18)) (CC and) (NML (NN Itpr1opt) (HYPH /) (NN opt))) (NNS mice)))))))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (DT this) (NN phenotype)) (VP (VBD was) (ADJP-PRD (JJ similar) (PP-1 (-NONE- *ICH*))) (, ,) (SBAR-ADV (IN although) (FRAG (ADJP (RBR less) (JJ severe)))) (, ,) (PP-1 (IN to) (NP (NP (DT that)) (VP (VBN described) (NP (-NONE- *)) (PP (IN in) (NP (NP (DT a) (NN mouse) (NN line)) (PP (IN with) (NP (NP (VBN targeted) (NN deletion)) (PP (IN of) (NP (NP (NN Itpr1)) (, ,) (SBAR (WHADVP-3 (WRB where)) (S (NP-SBJ-2 (NN ataxia)) (VP (VBD was) (VP (VBN described) (NP-2 (-NONE- *)) (PP-MNR (IN as) (NP (DT a) (JJ prominent) (NN feature))) (ADVP-LOC-3 (-NONE- *T*))))))))))))))) (PRN (-LRB- [) (NP (CD 4)) (-RRB- ]))) (. .)) )
( (S (PP (IN As) (PP (IN with) (NP (NP (DT the) (NML (NN Itpr1opt) (HYPH /) (NN opt)) (NNS mice)) (, ,) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ-1 (NP (DT the) (NN deletion)) (PP (IN of) (NP (NNS exons) (NML (CD 43) (CC and) (CD 44))))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN predicted) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB leave) (NP-3 (DT the) (JJ translational) (NN reading) (NN frame)) (S-CLR (NP-SBJ-3 (-NONE- *PRO*)) (ADJP-PRD (JJ unaffected)))))) (ADVP-LOC-2 (-NONE- *T*))))))))) (, ,) (NP-SBJ (DT the) (NML (PP (IN in) (HYPH -) (NP (NN frame)))) (NML (NN Itpr1Δ18) (HYPH /) (NN Δ18)) (NN deletion) (NN mutation)) (VP (VBZ results) (PP (IN in) (NP (NP (ADJP (RB markedly) (VBN decreased)) (NNS levels)) (PP (IN of) (NP (NN Itpr1))))) (PP-LOC (IN in) (NP (JJ cerebellar) (NNP Purkinje) (NNS cells)))) (. .)) )
( (S (PP-LOC (PP (IN In) (NP (DT these) (CD two) (JJ spontaneous) (NNS mutants) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ])))) (CC and) (PP (IN in) (NP (NP (DT the) (ADJP (NN Itpr1) (HYPH -) (JJ deficient)) (NN mouse) (PRN (-LRB- [) (NP (CD 4)) (-RRB- ]))) (VP (VBN generated) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NN gene) (NN targeting))))))) (, ,) (NP-SBJ-1 (VBN decreased) (NN Itpr1) (NN expression)) (VP (VBZ is) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (DT the) (JJ same) (JJ autosomal) (JJ recessive) (NN movement) (NN disorder))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (VBN Given) (NP (NP (PRP$ our) (NN interest)) (PP (IN in) (NP (JJ human) (JJ neurological) (NN disease))))) (NP-SBJ-1 (PRP we)) (VP (VBD sought) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (NP (DT any) (JJ cognate) (JJ human) (NNS disorders)) (SBAR (SBAR (WHADVP-4 (WRB where)) (S (NP-SBJ-2 (NP (NN linkage)) (PP-3 (-NONE- *ICH*))) (VP (VBD had) (VP (VBN been) (VP (VBN established) (NP-2 (-NONE- *)) (PP-3 (IN to) (NP (NP (DT the) (JJ syntenic) (NN region)) (PP (IN of) (NP (DT the) (JJ human) (NN genome))))) (ADVP-LOC-4 (-NONE- *T*))))))) (, ,) (CC but) (SBAR (WHADVP-5 (WRB where)) (S (NP-SBJ-6 (DT no) (JJ causal) (NN mutation)) (VP (VBD had) (VP (VBN been) (VP (VBN identified) (NP-6 (-NONE- *)) (ADVP-LOC-5 (-NONE- *T*))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN SCA15)) (, ,) (NP (DT an) (NML (JJ adult) (HYPH -) (NN onset)) (ADJP (JJ autosomal) (JJ dominant)) (JJ progressive) (NN ataxia))) (VP (VBZ is) (VP (VBN linked) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT this) (NN locus))) (PRN (-LRB- [) (NP (CD 5)) (-RRB- ])))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (S (NP-SBJ-1 (NP (NN missense) (NN mutation)) (PP (IN of) (NP (NN ITPR1)))) (VP (VBD had) (ADVP-TMP (RB previously)) (VP (VBN been) (VP (VBN ruled) (NP-1 (-NONE- *)) (PRT (RP out)) (PRN (-LRB- [) (NP (CD 2)) (-RRB- ])))))) (CC and) (S (NP-SBJ (NP (DT the) (NN mode)) (PP (IN of) (NP (NN inheritance)))) (VP (VBD was) (ADJP-PRD (JJ inconsistent) (PP (IN with) (NP (NP (DT that)) (VP (VBN seen) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN Itpr1Δ18) (CC and) (NN Itpr1opt)) (NNS mice))))))))))) (, ,) (NP-SBJ (NP (DT the) (JJ phenotypic) (NN presence)) (PP (IN of) (NP (NN ataxia))) (PP-LOC (IN in) (NP (DT the) (NNS mice)))) (VP (VBD led) (NP-2 (PRP us)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB reexamine) (NP (DT this) (NN candidate) (NN gene)) (PP (IN as) (NP (NP (DT a) (JJ possible) (NN cause)) (PP (IN of) (NP (NN SCA15))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD obtained) (NP (JJ genomic) (NN DNA)) (PP (IN from) (NP (NP (NP (CD three) (VBN affected) (NN family) (NNS members)) (CC and) (NP (NP (CD one) (NN family) (NN member)) (PP (IN with) (NP (JJ unknown) (NN disease) (NN status))))) (PP (IN from) (NP (NP (DT the) (NN kindred)) (VP (ADVP (RB originally)) (VBN used) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB define) (CC and) (VB map) (NP (NN SCA15) (PRN (-LRB- -LRB-) (NP (NP (NN family) (NN AUS1)) (, ,) (PP (IN of) (NP (JJ Australian) (ADJP (AFX Anglo) (HYPH -) (JJ Celtic)) (NN origin)))) (-RRB- -RRB-))))))))))) (PRN (-LRB- [) (NP (CD 2)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD performed) (NP (NP (CD two) (NNS experiments)) (NP-1 (-NONE- *ICH*))) (ADVP (RB concurrently)) (PP-LOC (IN in) (NP (NP (CD three) (VBN affected) (NNS members)) (PP (IN of) (NP (DT this) (NN family))))) (: :) (NP-1 (NP (NP (NN sequence) (NN analysis)) (PP (IN of) (NP (NP (DT the) (VBG coding) (NNS exons)) (PP (IN of) (NP (NN ITPR1)))))) (CC and) (NP (NML (JJ high) (HYPH -) (NN density)) (NML (NN genome) (HYPH -) (JJ wide)) (NN SNP) (NN genotyping)))) (. .)) )
( (S (NP-SBJ-1 (NN Sequence) (NN analysis)) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB show) (NP (NP (DT any) (NN coding) (NNS alterations)) (VP (VBG segregating) (PP (IN with) (NP (NP (NN disease)) (CC or) (NP (NP (DT any) (NNS alterations)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (ADJP-PRD (JJ inconsistent) (PP (IN with) (NP (NP (JJ Mendelian) (NNS patterns)) (PP (IN of) (NP (NN inheritance))) (PP (IN within) (NP (DT the) (NN family)))))))))))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (NN visualization)) (PP (IN of) (NP (NP (NML (NN log) (NN R)) (NN ratio)) (CC and) (NP (NP (NML (NN B) (NN allele)) (NN frequency) (NNS metrics)) (PP (IN from) (NP (DT the) (ADJP (NN genome) (HYPH -) (JJ wide)) (NN SNP) (NN genotyping) (NNS experiments))))))) (ADVP (RB clearly)) (VP (VBD showed) (NP (NP (NNS data)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT a) (JJ heterozygous) (JJ genomic) (NN deletion)) (PP-LOC (PP (IN across) (NP (NP (DT the) (JJ first) (CD one) (HYPH -) (NN third)) (PP (IN of) (NP (NN ITPR1))))) (CC and) (PP (IN across) (NP (NP (DT the) (JJ first) (NN half)) (PP (IN of) (NP (NP (DT a) (JJ neighboring) (NN gene)) (, ,) (NP (NN SUMF1))))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT This) (NN deletion)) (VP (VBD was) (ADJP-PRD (ADJP (JJ apparent) (PP-LOC (IN in) (NP (NP (DT all) (CD three) (VBN affected) (NN family) (NNS members)) (VP (VBN studied) (NP (-NONE- *)))))) (CC and) (ADJP (JJ absent) (PP (IN from) (NP (NP (DT the) (NN family) (NN member)) (PP (IN with) (NP (JJ unknown) (NN affection) (NN status))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 3)) (-RRB- -RRB-))) (. .)) )
( (S (S (NP-SBJ (DT The) (NN SNP) (NNS data)) (VP (VBD showed) (NP (NP (DT a) (NN deletion)) (PP (IN of) (PP (IN between) (NP (NP (NP (CD 188) (NN kb)) (CC and) (NP (CD 210) (NN kb))) (PP (IN in) (NP (NN size))))))))) (: ;) (S (NP-SBJ (NP (NN examination)) (PP (IN of) (NP (NP (NNS SNPs)) (PP-LOC (IN at) (NP (NP (DT the) (VBG flanking) (JJ unknown) (NNS regions)) (PP (IN of) (NP (DT this) (NN deletion)))))))) (VP (VBD allowed) (S (NP-SBJ (PRP us)) (VP (TO to) (VP (VB delimit) (NP (NP (DT the) (NNS borders)) (PP (IN of) (NP (DT the) (NN deletion)))) (PP (IN to) (NP (NP (NP (CD 7.5) (NN kb)) (PP-LOC (IN on) (NP (NP (DT the) (JJ telomeric) (NN side)) (PP (IN of) (NP (DT the) (NN deletion))) (-LRB- -LRB-) (PP (IN between) (NP (NN rs12634249) (CC and) (NN rs793396))) (-RRB- -RRB-)))) (CC and) (NP (NP (QP (SYM ~) (CD 14.4)) (NN kb)) (PP-LOC (IN on) (NP (NP (DT the) (JJ centromeric) (NN side)) (PP (IN of) (NP (DT the) (NN deletion))) (-LRB- -LRB-) (PP (IN between) (NP (NN rs4073665) (CC and) (NN rs17709863))) (-RRB- -RRB-))))))))))) (. .)) )
( (S (PP (IN In) (NP (DT an) (NN attempt) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB define) (SBAR (IN whether) (S (NP-SBJ (DT this) (NN variation)) (VP (VBD was) (NP-PRD (DT a) (JJ benign) (NN polymorphism)))))))))) (NP-SBJ-1 (PRP we)) (VP (VBD analyzed) (NP (NP (NP (ADJP (NN genome) (HYPH -) (JJ wide)) (NN SNP) (NNS data)) (PP-LOC (IN at) (NP (DT this) (NN locus)))) (, ,) (VP (VBN produced) (NP (-NONE- *)) (S-MNR (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (JJ same) (NN genotyping) (NN chip)) (, ,) (PP (IN from) (NP (NP (NP (CD 577) (NNS individuals)) (PP (IN of) (NP (JJ European) (NN descent)))) (SBAR (WHNP-2 (WP who)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (NP-PRD (CC either) (NP (NNS controls)) (CC or) (NP (NP (NNS individuals)) (PP (IN with) (NP (DT an) (JJ unrelated) (JJ neurological) (NN disorder)))))))))))))))) (. .)) )
( (S (S (NP-SBJ-1 (PRP We)) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB find) (NP (NP (DT any) (NNS deletions)) (VP (VBG affecting) (NP (NP (DT the) (NN coding) (NN sequence)) (PP (IN of) (NP (NP (DT either) (NN gene)) (, ,) (NP (NN ITPR1) (CC or) (NN SUMF1)))))))))))) (: ;) (S (NP-SBJ (PRP we)) (VP (VBD did) (, ,) (ADVP (RB however)) (, ,) (VP (VB identify) (NP (NP (DT a) (JJ single) (NN individual)) (PP (IN with) (NP (NP (DT a) (JJ possible) (JJ heterozygous) (NN deletion)) (NP-ADV (NP (QP (RB approximately) (CD 6)) (NN kb)) (PP (IN in) (NP (NN size)))) (PP-LOC (IN within) (NP (NP (NN intron) (NML (NML (CD 40)) (PP (SYM –) (NP (CD 41))))) (PP (IN of) (NP (NN ITPR1))) (, ,) (ADVP-LOC (NP (QP (RB at) (RBS least) (CD 5)) (NN kb)) (RB away) (PP (IN from) (NP (NN exon) (CD 40)))))))))))) (. .)) )
( (S (PP (VBN Given) (NP (NP (DT the) (NN location)) (PP (IN of) (NP (DT this) (NN alteration))))) (NP-SBJ-1 (PRP it)) (VP (VBZ is) (ADJP-PRD (JJ unlikely) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB effect) (NP (NP (DT the) (NML (NN expression) (CC or) (NN splicing))) (PP (IN of) (NP (NN ITPR1))))))))) (. .)) )
( (S (PP (IN In) (NP (DT an) (NN attempt) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (RB fine) (HYPH -) (VB map) (NP (NP (DT the) (NNS breakpoints)) (PP (IN of) (NP (DT the) (ADJP (NN disease) (HYPH -) (VBG causing)) (NN deletion))))))))) (NP-SBJ (PRP we)) (VP (VBD performed) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (NNS experiments)) (VP (VBN designed) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB refine) (NP (DT the) (JJ unknown) (NNS intervals)) (PP (IN at) (NP (NP (DT the) (NNS edges)) (PP (IN between) (NP (ADJP (ADJP (JJ definite) (VBN deleted)) (CC and) (ADJP (JJ definite) (JJ diploid))) (NNS sequences))))))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBD narrowed) (NP (DT the) (JJ unknown) (NNS borders)) (PP (IN to) (NP (NP (NP (QP (SYM ~) (CD 4)) (NN kb)) (PP-LOC (IN on) (NP (DT the) (JJ telomeric) (NN side)))) (CC and) (NP (NP (QP (SYM ~) (CD 7)) (NN kb)) (PP-LOC (IN on) (NP (DT the) (JJ centromeric) (NN side))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD used) (NP (NP (DT all) (JJ possible) (NNS combinations)) (PP (PP (IN of) (NP (NP (NML (JJ forward) (NN orientation)) (NNS primers)) (VP (VBN designed) (NP (-NONE- *)) (PP-LOC (IN within) (NP (DT the) (ADJP (RB newly) (VBN defined)) (JJ telomeric) (NN boundary)))))) (CC and) (PP (IN of) (NP (NP (NML (JJ reverse) (NN orientation)) (NNS primers)) (VP (VBN designed) (NP (-NONE- *)) (PP-LOC (IN within) (NP (DT the) (ADJP (RB newly) (VBN defined)) (JJ centromeric) (NN boundary)))))))) (PP (IN in) (NP (NN PCR) (NNS assays))) (PP (IN in) (NP (DT an) (NN attempt) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB amplify) (PP (IN across) (NP (NP (DT the) (NN deletion)) (PP-LOC (IN in) (NP (VBN affected) (NN family) (NNS members))))))))))) (. .)) )
( (S (S-MNR (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBG Using) (NP (NP (NP (NN PCR) (NNS primers)) (NP (NN T3F) (CC and) (NN C11R))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD should) (VP (VB be) (ADVP-LOC-PRD (NP (QP (JJR more) (IN than) (CD 200)) (NN kb)) (RB apart))))))))) (, ,) (NP-SBJ-2 (PRP we)) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB amplify) (NP (NP (DT a) (NN fragment)) (NP-ADV (NP (CD 953) (NN bp)) (PP (IN in) (NP (NN size))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NN DNA)) (PP (IN from) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (CD three) (VBN affected) (NN family) (NNS members)))))) (PP-MNR (IN as) (NP (NN template)))))))))) (. .)) )
( (S (NP-SBJ (NP (NN Sequencing)) (PP (IN of) (NP (DT this) (NN fragment)))) (VP (VBD revealed) (NP (NP (DT a) (NN deletion)) (PP (IN of) (NP (CD 201,509) (NN bp)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S3)) (-RRB- -RRB-)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG removing) (NP (NP (NP (DT the) (JJ first) (CD three)) (PP (IN of) (NP (NP (DT the) (CD nine) (NNS exons)) (PP (IN of) (NP (NN SUMF1)))))) (CC and) (NP (NP (DT the) (JJ first) (CD ten)) (PP (IN of) (NP (NP (DT the) (CD 58) (NNS exons)) (PP (IN of) (NP (NN ITPR1)))))))))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBD were) (ADJP-PRD (JJ unable) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB amplify) (NP (NP (DT the) (ADJP (NN deletion) (HYPH -) (JJ specific)) (NN fragment)) (PP-LOC (PP (IN in) (NP (NP (DT the) (NN family) (NN member)) (PP (IN of) (NP (JJ unknown) (NN affection) (NN status))))) (, ,) (CC or) (PP (IN in) (NP (CD 275) (ADJP (RB neurologically) (JJ normal)) (NNS controls)))))))))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (ADVP (RB further)) (VP (VB establish) (NP (NP (JJ genetic) (NN deletion)) (PP-LOC (IN at) (NP (NN ITPR1)))) (PP (IN as) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (NN SCA15)))))))) (NP-SBJ-1 (PRP we)) (VP (VBD analyzed) (NP (NP (CD two) (JJ additional) (NNS families)) (PP (IN with) (NP (NP (DT an) (VBN inherited) (JJ cerebellar) (NN ataxia)) (ADJP (JJ similar) (PP (IN to) (NP (NP (DT that)) (VP (VP (VBN described) (NP (-NONE- *)) (PP (IN in) (NP (DT the) (NN AUS1) (NN family)))) (, ,) (VP (VBN ascertained) (NP (-NONE- *)) (PP-MNR (IN through) (NP (NP (NN neurology) (NNS clinics)) (PP-LOC (IN in) (NP (NP (NNP London)) (, ,) (NP-LOC (NNP United) (NNP Kingdom))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN DNA)) (VP (VBN extracted) (NP (-NONE- *)) (PP (IN from) (NP (NP (NNS probands)) (PP (IN from) (NP (DT these) (CD two) (NNS families) (PRN (-LRB- -LRB-) (NP (NP (NN family) (NN H33)) (CC and) (NP (NN family) (NN H27))) (-RRB- -RRB-)))))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN analyzed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NNP Illumina) (NNP Infinium) (NNP HumanHap550)) (NN genotyping) (NNS chips)))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS experiments)) (VP (VBD showed) (NP (NN deletion)) (PP-LOC (IN at) (NP (DT the) (NN SCA15) (NN locus))) (PP-LOC (IN in) (NP (NP (NP (DT all) (VBN affected) (NNS members)) (VP (VBN assayed) (NP (-NONE- *)))) (, ,) (PP (PP (IN from) (NP (NN SUMF1))) (PP (IN through) (NP (NN ITPR1))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS mutations)) (VP (VBD segregated) (PP (IN with) (NP (NP (NN disease)) (PP (IN in) (NP (DT these) (CD two) (NNS families))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S3)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (DT A) (NN strategy)) (ADJP (JJ similar) (PP (IN to) (NP (NP (DT the) (CD one)) (VP (VBN outlined) (NP (-NONE- *)) (ADVP (RB above))))))) (VP (VBD enabled) (NP-1 (PRP us)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB sequence) (PP (IN over) (NP (DT the) (NN breakpoint))) (PP (IN in) (NP (NP (NN family) (NN H27)) (CONJP (CC but) (RB not)) (NP (NN family) (NN H33)))))))) (. .)) )
( (S (S (PP (IN In) (NP (DT the) (JJ former))) (, ,) (NP-SBJ (DT the) (NN deletion)) (VP (VBZ spans) (NP (CD 344,408) (NN bp)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG removing) (NP (NP (NP (NNS exons) (NML (NML (CD 1)) (PP (SYM –) (NP (CD 3))))) (PP (IN of) (NP (NN SUMF1)))) (CC and) (NP (NP (CD 1)) (PP (SYM –) (NP (CD 44))) (PP (IN of) (NP (NN ITPR1))))))))) (: ;) (S (PP-LOC (IN in) (NP (DT the) (JJ latter))) (, ,) (NP-SBJ (PRP we)) (VP (VBP estimate) (SBAR (SBAR (IN that) (S (NP-SBJ (DT the) (NN deletion)) (VP (VBZ is) (NP-PRD (NP (CD 310) (NN kb)) (PP (IN in) (NP (NN length))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (PRP it)) (VP (VBZ removes) (NP (NP (NP (NNS exons) (NML (NML (CD 1)) (PP (SYM –) (NP (CD 3))))) (PP (IN of) (NP (NN SUMF1)))) (CC and) (NP (NP (NNS exons) (NML (NML (CD 1)) (PP (SYM –) (NP (CD 40))))) (PP (IN of) (NP (NN ITPR1))))))))))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NN site)) (PP (IN of) (NP (NN mutation)))) (VP (VBZ is) (PP-PRD (IN of) (NP (NN interest))) (, ,) (NP-ADV (ADVP (RB particularly)) (DT the) (NN fact) (SBAR (IN that) (S (PP (IN in) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (CD three) (NNS families))))) (NP-SBJ-1 (NP (DT the) (JJ telomeric) (NN end)) (PP (IN of) (NP (DT the) (NN deletion)))) (VP (VBZ is) (VP (VBN anchored) (NP-1 (-NONE- *)) (PP-LOC (IN between) (NP (NP (NNS exons) (NML (CD 3) (CC and) (CD 4))) (PP (IN of) (NP (NN SUMF1)))))))))))) (: ;) (S (NP-SBJ-2 (NN sequence) (NNS searches)) (VP (VBD failed) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB identify) (NP (NP (DT any) (NN repeat) (NNS sequences)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (MD might) (VP (VB explain) (NP (DT this) (NN phenomenon)))))))))))) (. .)) )
( (S (PP (IN With) (NP (NP (NP (CD three) (JJ cerebellar) (NN ataxia) (NNS families)) (VP (VBG segregating) (NP (DT a) (NML (NN SUMF1) (HYPH –) (NN ITPR1)) (NN deletion)))) (, ,) (CC and) (NP (NP (DT this) (NN deletion)) (VP (RB not) (VBN observed) (NP (-NONE- *)) (PP (IN in) (NP (DT a) (NN control) (NN population))))))) (, ,) (NP-SBJ (PRP we)) (VP (MD may) (ADVP (RB reasonably)) (VP (VB conclude) (SBAR (SBAR (IN that) (S (NP-SBJ (DT the) (NN association)) (VP (VBZ is) (ADJP-PRD (JJ causal))))) (, ,) (CC and) (SBAR (IN that) (S (NP-SBJ (DT the) (NN deletion)) (VP (VBZ is) (ADVP (RB indeed)) (NP-PRD (NP (DT the) (JJ genetic) (NN basis)) (PP (IN of) (NP (DT the) (NN disease)))) (, ,) (SBAR-ADV (IN with) (S (NP-SBJ (NN SCA15)) (NP-PRD (NP (DT the) (NN diagnosis)) (PP (IN in) (NP (NP (DT the) (CD two) (JJ British) (NNS families)) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (JJ original) (JJ Australian) (NN family))))))))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ improbable)) (SBAR-1 (IN that) (S (NP-SBJ (NP (NP (NP (NN heterozygosity)) (PP (IN for) (NP (NP (DT the) (NN deletion)) (PP (IN of) (NP (NN SUMF1)))))) (, ,) (VP (VBG encoding) (NP (NN sulfatase) (VBG modifying) (NN factor) (CD 1)))) (, ,) (PP (IN of) (NP (PRP itself)))) (VP (VP (VBZ causes) (NP-2 (-NONE- *RNR*))) (CC or) (VP (VBZ contributes) (PP (IN to) (NP-2 (-NONE- *RNR*)))) (NP-2 (NN SCA15)))))) (. .)) )
( (S (NP-SBJ (NP (JJ Homozygous) (NN mutation)) (PP (IN of) (NP (NN SUMF1)))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ autosomal) (JJ recessive) (JJ multiple) (NN sulfatase) (NN deficiency)) (, ,) (NP (NP (DT a) (JJ metabolic) (NN disorder)) (VP (VBN characterized) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NN hepatosplenomegaly)) (, ,) (NP (NN deafness)) (, ,) (CC and) (NP (JJ developmental) (NN delay)))))))) (PRN (-LRB- [) (NP (CD 6) (, ,) (CD 7)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-1 (NP (DT No) (NN co-occurrence)) (PP (IN of) (NP (NN ataxia))) (PP-LOC-2 (-NONE- *ICH*))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP-1 (-NONE- *)) (PP-LOC-2 (IN in) (NP (-LRB- -LRB-) (NP (JJ heterozygous) (-RRB- -RRB-) (NNS parents)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ multiple) (NN sulfatase) (NN deficiency)))))))))) (. .)) )
( (S (ADVP (RB Conversely)) (, ,) (S (S (NP-SBJ (NP (NN mutation)) (PP (IN of) (NP (NN ITPR1)))) (VP (VBZ is) (ADJP-PRD (RB biologically) (JJ plausible)) (PP (IN as) (NP (NP (DT a) (NN cause)) (PP (IN of) (NP (NN ataxia))))))) (: :) (S (S (NP-SBJ-1 (DT the) (NN protein)) (VP (VBZ is) (ADVP (RB highly)) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NNP Purkinje) (NNS cells)))))) (: ;) (S (S (SBAR-ADV (IN as) (S (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN shown) (ADVP (RB here)))))) (, ,) (NP-SBJ (NP (NNS mice)) (PP (IN with) (NP (NP (NN mutation)) (PP (IN at) (NP (DT this) (NN locus)))))) (VP (VBP present) (PP (IN with) (NP (NN ataxia))))) (: ;) (CC and) (S (NP-SBJ-2 (VBN perturbed) (NN Ca2+) (NN signaling)) (VP (VBZ has) (ADVP-TMP (RB previously)) (VP (VBN been) (VP (VBN implicated) (NP-2 (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN etiology)) (PP (IN of) (NP (NN ataxia))))) (, ,) (PP-LOC (ADVP (RB notably)) (IN in) (NP (NP (JJ episodic) (NN ataxia) (NN type) (CD 2)) (CC and) (NP (NN SCA6)))) (PRN (-LRB- [) (NP (CD 8)) (-RRB- ]))))))))) (. .)) )
( (S (PP (IN In) (NP (NP (JJ further) (NN support)) (PP (IN of) (NP (DT this) (NN conclusion))))) (, ,) (NP-SBJ (NP (NN analysis)) (PP (IN of) (NP (NP (NN protein) (NNS levels)) (PP (IN of) (NP (NP (NN ITPR1)) (PP-LOC (IN in) (NP (NP (NML (NML (NML (NN Epstein) (HYPH -) (NN Barr)) (NN virus)) (-LRB- -LRB-) (NML (NN EBV))) (-RRB- -RRB-) (VBN immortalized) (NNS lymphocytes)) (PP (IN from) (NP (ADJP (VBN affected) (CC and) (JJ unaffected)) (NN AUS1) (NN family) (NNS members)))))))))) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (DT all) (VBN affected) (NNS members)) (VP (VBD showed) (NP (NP (DT a) (JJ dramatic) (NN decrease)) (PP (IN in) (NP (NN ITPR1) (NNS levels)))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (DT the) (NN family) (NN member)) (PP (IN without) (NP (DT the) (NN deletion))))) (ADVP-TMP-2 (-NONE- *T*)))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4)) (-RRB- -RRB-))) (. .)) )
( (S (S (NP-SBJ (NN Itpr1)) (VP (VBZ contains) (NP (NP (CD three) (NNS domains)) (, ,) (NP (NP (DT an) (ADJP (NN N) (HYPH -) (JJ terminal)) (NN inositol) (NN triphosphate) (NN binding) (NN domain)) (, ,) (NP (DT a) (VBG coupling) (NN domain)) (, ,) (CC and) (NP (DT a) (ADJP (NN C) (HYPH -) (JJ terminal)) (NN transmembrane) (NN domain)))))) (: ;) (S (NP-SBJ (PRP it)) (ADVP (RB also)) (VP (VBZ contains) (NP (NP (CD two) (NML (NN protein) (NN kinase) (NN A)) (NN phosphorylation) (NNS sites)) (CC and) (NP (DT an) (ADJP (NN ATP) (HYPH -) (VBG binding)) (NN site))))) (. .)) )
( (S (NP-SBJ-1 (NN Itpr1)) (VP (VP (VBZ is) (VP (VBN coupled) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN Ca2+) (NNS channels))))) (CC and) (VP (VBZ facilitates) (NP (NP (NN Ca2+) (NN release)) (PP (IN from) (NP (DT the) (JJ endoplasmic) (NN reticulum))) (PP-TMP (IN after) (NP (NP (NN binding)) (PP (IN by) (NP (NP (DT the) (JJ intracellular) (JJ second) (NN messenger)) (NP (NN inositol) (NML (CD 1) (, ,) (CD 4) (, ,) (CD 5)) (HYPH -) (NN triphosphate)))))))) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-1 (NN Itpr1)) (VP (VBZ is) (VP (VBN enriched) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (NNP Purkinje) (NNS cells)) (PP (IN of) (NP (DT the) (NN cerebellum))))) (PRN (-LRB- [) (NP (CD 4)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NN ITPR1) (NNS mutations)) (VP (VBP have) (NP (QP (JJR more) (IN than) (CD one)) (JJ potential) (JJ pathogenic) (NN mechanism))) (. .)) )
( (S (ADVP (RB First)) (, ,) (S (S (NP-SBJ (DT the) (NN disease)) (VP (MD may) (VP (VB be) (NP-PRD (NP (DT a) (NN result)) (PP (IN of) (NP (NP (NN haploinsufficiency)) (PP-LOC (IN at) (NP (NN ITPR1))))))))) (: ;) (S (NP-SBJ (DT this) (NN concept)) (VP (VBZ is) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (DT the) (NN observation) (SBAR (IN that) (S (NP-SBJ (JJ heterozygous) (NN deletion)) (VP (VBZ leads) (PP (IN to) (NP (DT a) (NML (JJ later) (NN onset)) (NN disorder))) (PP-LOC (IN in) (NP (NNS humans))) (, ,) (SBAR-ADV (IN whereas) (S (NP-SBJ (NP (JJ homozygous) (NN deletion)) (PP-LOC (IN in) (NP (NNS mice)))) (VP (VBZ leads) (PP (IN to) (NP (NP (DT an) (NML (JJ early) (NN onset)) (NN disorder)) (, ,) (ADJP (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB be) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-TMP (IN within) (NP (NP (DT the) (ADJP (RB much) (JJR shorter)) (NN life) (NN span)) (PP (IN of) (NP (DT the) (NN mouse)))))))))))))))))))))))) (. .)) )
( (S (ADVP (RB Second)) (, ,) (S (NP-SBJ (PRP we)) (VP (MD can) (RB not) (VP (VB rule) (PRT (RP out)) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NP (NP (DT an) (JJ alternate) (NN start) (NN site)) (PP (IN for) (NP (NN ITPR1)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT a) (NN product)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ confers) (NP (NP (DT a) (JJ pathogenic) (NN gain)) (PP (IN of) (NP (NN function)))) (PP (IN to) (NP (DT the) (NN protein)))))))))))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP-SBJ-4 (NP (NP (NML (NNP Western) (NN blot)) (NN analysis)) (PP (IN of) (NP (NP (NNS cells)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (VBN affected) (NML (NN AUS1) (NN family)) (NNS members))))))) (, ,) (SBAR (WHNP-3 (WDT which)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBD was) (VP (VBN performed) (NP-3 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT an) (NN antibody)) (VP (VBN raised) (NP (-NONE- *)) (PP (IN against) (NP (NP (DT the) (ADJP (NN C) (HYPH -) (JJ terminal)) (NN portion)) (PP (IN of) (NP (NN ITPR1)))))))))))))) (, ,) (VP (VBD failed) (S (NP-SBJ-4 (-NONE- *)) (VP (TO to) (VP (VB identify) (NP (DT any) (ADJP (NN disease) (HYPH -) (JJ specific)) (NML (VBN truncated) (NN protein)) (NNS products))))))) (. .)) )
( (S (ADVP (RB Clearly)) (, ,) (NP-SBJ-1 (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (JJ distinct) (NN ITPR1) (NNS mutations)) (VP (VBG underlying) (NP (NN SCA15)))))) (VP (MD will) (VP (VB help) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VB elucidate) (NP (NP (DT the) (JJ pathogenic) (NN mechanism)) (PP (IN of) (NP (DT this) (NN disorder)))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP show) (ADVP (RB here)) (NP (NP (DT the) (NN utility)) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG investigating) (NP (JJ spontaneous) (NN mouse) (NNS mutations)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG understanding) (NP (JJ human) (NN disease)))))))))) (. .)) )
( (S (S (ADVP (RB Currently)) (, ,) (NP-SBJ (NP (DT the) (JJ small) (NN number)) (PP (IN of) (NP (VBN aged) (NML (NN Itpr1wt) (HYPH /) (NN Δ18)) (NNS animals)))) (VP (VBZ precludes) (NP (PRP us)) (PP (IN from) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG examining) (NP (DT these) (NNS mice)) (PP (IN for) (NP (NP (JJ subtle) (NML (NNS signs) (CC and) (NNS symptoms))) (ADJP (JJ similar) (PP (IN to) (NP (NP (DT those)) (VP (VBN seen) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN SCA15) (NNS patients)))))))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP-SBJ (DT these) (NNS mice)) (VP (VBP are) (ADVP (RB clearly)) (PP-PRD (IN of) (NP (NP (NN interest)) (PP (IN to) (NP (PRP us))))) (PP (IN as) (NP (NP (DT a) (JJ potential) (NN model)) (PP (IN of) (NP (NN SCA15))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (ADVP (RB also)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (ADJP (NN genome) (HYPH -) (JJ wide)) (NN SNP) (NN assay)) (VP (MD can) (VP (VB facilitate) (NP (NP (JJ rapid) (NN detection)) (PP (IN of) (NP (NP (JJ structural) (JJ genomic) (NNS mutations)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD may) (VP (VB underlie) (NP (NN disease)))))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS data)) (VP (VBN provided) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT these) (NNS approaches))))) (VP (VBP provide) (NP (JJ compelling) (NN evidence) (SBAR (IN that) (S (NP-SBJ (NP (JJ heterozygous) (NN deletion)) (PP (IN of) (NP (NN ITPR1)))) (VP (VBZ causes) (NP (NN SCA15))))))) (. .)) )
( (S (S (ADVP (RB Clearly)) (, ,) (NP-SBJ (NP (NN sequence) (NN analysis)) (PP (IN of) (NP (NP (NN ITPR1)) (PP (IN in) (NP (JJ potential) (NN SCA15) (NNS cases)))))) (VP (MD may) (VP (VB provide) (NP (NP (JJ additional) (NN insight)) (PP (IN into) (NP (DT the) (NN disease)))) (, ,) (SBAR-ADV (ADVP (RB particularly)) (IN if) (S (NP-SBJ-1 (DT a) (NN stop) (NN mutation)) (VP (VBD were) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN identified) (NP-1 (-NONE- *)))))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP-SBJ (NP (DT the) (JJ mutational) (NN mechanism)) (VP (VBN noted) (NP (-NONE- *)) (ADVP (RB here)))) (VP (VBZ means) (SBAR (IN that) (S (S (NP-SBJ-2 (NP (JJ standard) (NN sequencing) (NNS approaches)) (ADVP (RB alone))) (VP (VBP are) (ADJP-PRD (JJ insufficient) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (ADVP (RB confidently)) (VP (VB rule) (PRT (RP out)) (NP (NN ITPR1) (NN mutation)) (PP (IN as) (NP (NP (DT a) (NN cause)) (PP (IN of) (NP (NN disease))))))))))) (: :) (S (NP-SBJ-3 (DT a) (JJ comprehensive) (NML (NN gene) (NN dosage)) (NN approach)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN required) (NP-3 (-NONE- *))))))))) (. .)) )
( (S (PP (VBN Given) (SBAR (IN that) (S (NP-SBJ-1 (NP (NN SCA16)) (CC and) (NP (JJ autosomal) (JJ dominant) (JJ congenital) (JJ nonprogressive) (NN ataxia))) (VP (VBP have) (DT both) (ADVP (RB recently)) (VP (VBN been) (VP (VBN mapped) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NNS regions)) (VP (VBG overlapping) (PP (IN with) (NP (DT the) (NN SCA15) (NN locus)))))) (PRN (-LRB- [) (NP (CD 10) (, ,) (CD 11)) (-RRB- ])))))))) (, ,) (NP-SBJ (NN ITPR1)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN gene)) (PP (IN of) (NP (NP (NN importance)) (PP (IN for) (NP (NN screening)))))) (PP (IN in) (NP (DT these) (NNS families)))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP add) (NP (NN weight)) (PP (IN to) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NP (JJ aberrant) (JJ intracellular) (NN Ca2+) (NN signaling)) (PP-LOC (IN in) (NP (NNP Purkinje) (NNS cells))))) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (JJ spinocerebellar) (NN ataxia)))))))) (. .)) )
( (HEADING (NP (NNS Materials) (CC and) (NNS Methods))) )
( (HEADING (NP (NP (ADJP (NN Genome) (HYPH -) (JJ wide)) (NN linkage)) (PP-LOC (IN in) (NP (NNS mice))) (. .))) )
( (S (NP-SBJ-1 (QP (CD One) (CD hundred) (CC and) (CD twenty)) (NN DNA) (NNS fragments)) (VP (VBD were) (VP (VBN amplified) (NP-1 (-NONE- *)) (PP-LOC (IN across) (NP (DT the) (NN genome))) (, ,) (NP-ADV (NP (DT each)) (VP (VBN selected) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB contain) (NP (NP (QP (CD one) (CC or) (JJR more)) (ADJP (NN strain) (HYPH -) (JJ specific)) (NNS SNPs)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (MD would) (VP (VB differentiate) (PP (IN between) (NP (NML (NML (NN C57BL) (HYPH /) (NN 6J)) (CC and) (NML (NN 129x1) (HYPH /) (NN SvJ))) (JJ inbred) (NNS strains))))))))))))) (PRN (-LRB- [) (NP (CD 12)) (-RRB- ])))) (. .)) )
( (S (S (NP-SBJ-1 (DT Each) (NN fragment)) (VP (VBD was) (ADVP (RB initially)) (VP (VBN amplified) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (CD 11) (VBN affected) (NNS mice)) (CC and) (NP (CD nine) (JJ unaffected) (NNS mice))))))) (: ;) (S (NP-SBJ-2 (NN genotype) (NN calling)) (VP (VBD was) (VP (VBN performed) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NML (NN dye) (HYPH -) (NN terminator)) (NN sequencing)) (PP (IN of) (NP (DT these) (NNS fragments)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Linkage) (NN analysis)) (VP (VBG using) (NP (DT these) (NNS data)))) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN mlink)) (PRN (-LRB- [) (NP (CD 13)) (-RRB- ])))) (, ,) (SBAR-ADV (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD revealed) (NP (DT a) (JJ positive) (NN linkage)) (PP-LOC (IN at) (NP (NN Chromosome) (NN 6qE1))) (, ,) (PP (IN on) (NP (DT the) (NML (NN 129x1) (HYPH /) (NN SvJ)) (NN background) (PRN (-LRB- -LRB-) (NP (NP (NML (CD two) (HYPH -) (NN point)) (NN LOD) (NN score) (CD 5.13)) (PP (IN at) (NP (NN marker) (NN 20.MMHAP85FLG2)))) (-RRB- -RRB-))))))))) (. .)) )
( (S (PP (IN In) (NP (DT an) (NN attempt) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB narrow) (NP (DT the) (NN disease) (NN interval))))))) (NP-SBJ (PRP we)) (VP (VBD performed) (NP (NP (NN backcross) (NNS experiments)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (CD three) (JJ additional) (VBN affected) (NNS mice)))))))))) (. .)) )
( (S (NP-SBJ (NP (NN Genotyping)) (PP (IN of) (NP (DT all) (VBN affected) (NNS mice))) (PP (IN across) (NP (DT the) (ADJP (NN disease) (HYPH -) (VBG segregating)) (NN interval)))) (VP (VBD revealed) (NP (NP (VBG flanking) (NNS recombinants)) (CC and) (NP (NP (DT a) (NN candidate) (NN region)) (PP (IN of) (NP (QP (SYM ~) (CD 5)) (NN Mb))))) (, ,) (PP-LOC (IN between) (NP (NNS markers) (NML (NML (NN D6Mit37)) (CC and) (NML (NN 44.MMHAP85FLG5))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S1)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT This) (NN region)) (VP (VBZ contains) (NP (NP (CD 16) (NNS genes)) (CC and) (NP (VBN predicted) (NNS transcripts)))) (. .)) )
( (HEADING (NP (NP (NN Identification)) (PP (IN of) (NP (DT the) (VBG underlying) (JJ genetic) (NN lesion))) (PP-LOC (IN in) (NP (NNS mice))) (. .))) )
( (S (NP-SBJ-1 (NP (NN Identification)) (PP (IN of) (NP (NP (JJ similar) (NNS phenotypes)) (PP-LOC (IN in) (NP (NP (NNS mice)) (VP (VBN linked) (NP (-NONE- *)) (PP (IN to) (NP (DT the) (NN 6qE1) (NN interval))))))))) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN literature) (NNS searches))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBD revealed) (NP (NP (DT the) (NML (NN Itpr1opt) (HYPH /) (NN opt)) (NN mouse)) (, ,) (SBAR (WHPP-2 (IN in) (WHNP (WDT which))) (S (NP-SBJ-1 (NN disease)) (VP (VBZ is) (VP (VBN caused) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (JJ homozygous) (NN deletion) (NN mutation)) (PP (IN of) (NP (NP (NNS exons) (NML (CD 43) (CC and) (CD 44))) (PP (IN of) (NP (NN Itpr1))))))) (PP-LOC-2 (-NONE- *T*)))))))) (. .)) )
( (S (NP-SBJ-1 (NN Primer) (NNS pairs)) (VP (VBD were) (VP (VBN designed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB sequence) (NP (NP (NP (NP (DT each)) (PP (IN of) (NP (DT the) (NN coding) (NNS exons)))) (CC and) (NP (NP (QP (RB at) (RBS least) (CD 50)) (NN bp)) (PP (IN of) (NP (DT each) (VBG flanking) (JJ intronic) (NN sequence))))) (PP (IN of) (NP (NN Itpr1))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN PCR) (NN amplification)) (PP (IN of) (NP (DT each) (NN exon)))) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NN DNA)) (PP (IN from) (NP (CD two) (VBN affected) (NNS mice)))) (PP-MNR (IN as) (NP (NNS templates))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NN Itpr1Δ18) (HYPH /) (NN Δ18)) (NN mutation)) (VP (VBD was) (VP (VBN confirmed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN sequencing))) (PP-LOC (IN in) (NP (DT all) (VBN affected) (NNS mice))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S2)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (VBG Breeding) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN between) (NP (NP (NP (CD two) (JJ female) (NNS mice)) (ADJP (JJ heterozygous) (PP (IN for) (NP (DT the) (JJ current) (NN mutation) (PRN (-LRB- -LRB-) (NP (NN Itpr1wt) (HYPH /) (NN Δ18)) (-RRB- -RRB-)))))) (CC and) (NP (NP (DT a) (JJ male) (NN mouse)) (ADJP (JJ heterozygous) (PP (IN for) (NP (DT the) (NN Itpr1opt) (NN mutation) (PRN (-LRB- -LRB-) (NP (NN Itpr1wt) (HYPH /) (NN opt)) (-RRB- -RRB-)))))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBD resulted) (PP (IN in) (NP (NP (CD two) (NNS litters)) (PP (IN of) (NP (NNS mice))) (PP (IN with) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD four) (VBN affected) (NML (NN Itpr1opt) (HYPH /) (NN Δ18)) (NNS pups) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 15))))) (: ;) (NP (NP (QP (CD two) (IN of) (CD seven))) (PP (IN from) (NP (JJ first) (NN mating)))) (: ;) (NP (NP (QP (CD two) (IN of) (CD eight))) (PP (IN from) (NP (DT the) (JJ second) (NN mating)))) (-RRB- -RRB-))) (PP (IN with) (NP (NP (DT a) (NN phenotype)) (ADJP (JJ indistinguishable) (PP (IN from) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (NML (NML (NN Itpr1Δ18) (HYPH /) (NN Δ18)) (CC and) (NML (NN Itpr1opt) (HYPH /) (NN opt))) (NNS mice))))))))))))))) (. .)) )
( (HEADING (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (NN Itpr1) (NN protein)) (PP-LOC (IN in) (NP (NNS mice))))) (. .))) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBD performed) (NP (NML (NNP Western) (NN blot)) (NNS analyses)) (S-MNR (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG using) (NP (JJ standard) (NNS techniques)))) (PP-MNR (IN with) (NP (NN ECL) (NN detection) (NNS kits) (PRN (-LRB- -LRB-) (NP (NP (NNP Amersham)) (, ,) (NP-ADV (NN http://www.amersham.com))) (-RRB- -RRB-))))) (. .)) )
( (S (ADVP (RB Briefly)) (, ,) (NP-SBJ-1 (NP (VBN dissected) (JJ whole) (NNS brains)) (PP (IN from) (NP (NML (JJ postnatal) (NN day) (CD 21)) (NNS littermates)))) (VP (VBD were) (VP (VBN homogenized) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT a) (NN buffer)) (VP (VBG containing) (NP (NP (NML (CD 50) (NN mM)) (NN Tris) (HYPH -) (NN HCl)) (, ,) (NP (NML (CD 150) (NN mM)) (NN NaCl)) (, ,) (NP (NML (CD 1) (NN mM)) (NN EDTA)) (, ,) (NP (NML (CD 1) (NN %)) (NN Triton) (NN X) (HYPH -) (CD 100)) (, ,) (NP (NML (CD 1) (NN %)) (NN sodium) (NN deoxycholate)) (, ,) (NP (NML (CD 0.1) (NN %)) (NN SDS)) (, ,) (CC and) (NP (NP (DT a) (NN cocktail)) (PP (IN of) (NP (NN protease) (NNS inhibitors)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Roche)) (, ,) (NP-ADV (NN http://www.roche.com))) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Homogenates)) (VP (VBD were) (VP (VP (VBN diluted) (NP-1 (-NONE- *)) (ADVP (RB appropriately))) (, ,) (VP (VBN mixed) (NP-1 (-NONE- *)) (PP (IN with) (NP (QP (CD 4) (SYM ×)) (VBG reducing) (NN sample) (NN buffer)))) (, ,) (CC and) (VP (VBN loaded) (NP-1 (-NONE- *)) (PP (IN onto) (NP (NML (NML (CD 4) (NN %)) (PP (SYM –) (NP (CD 12) (NN %)))) (NN precast) (NN gradient) (NNS gels) (PRN (-LRB- -LRB-) (NP (NP (NNP Novex)) (, ,) (NP-ADV (NN http://www.invitrogen.com))) (-RRB- -RRB-)))) (PP-PRP (IN for) (NP (NP (NN SDS) (HYPH -) (NN PAGE)) (CC and) (NP (NN immunoblotting))))))) (. .)) )
( (S (NP-SBJ-2 (NP (DT The) (NNS antibodies)) (PP (IN to) (NP (NP (NN Itpr1) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM :) (NP (CD 2,000)))) (-RRB- -RRB-))) (CC and) (NP (NN Actb) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM :) (NP (CD 5,000)))) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN used) (NP-2 (-NONE- *)) (SBAR-MNR (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN recommended) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NNS manufacturers)))))))) (. .)) )
( (HEADING (NP (NN Immunohistochemistry) (. .))) )
( (S (NP-SBJ-1 (NNS Brains)) (VP (VBD were) (VP (VP (VBN isolated) (NP-1 (-NONE- *)) (PP (IN from) (NP (ADJP (NP (CD 21) (HYPH -) (NN d)) (HYPH -) (JJ old)) (NNS mice)))) (, ,) (VP (VBN perfused) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NML (CD 4) (NN %)) (NN paraformaldehyde)) (PP (IN in) (NP (NN PBS)))))) (, ,) (CC and) (VP (VBN post-fixed) (NP-1 (-NONE- *)) (ADVP-TMP (RB overnight)) (PP-MNR (IN in) (NP (DT the) (JJ same) (NN fixative)))))) (. .)) )
( (S (S (NP-SBJ-1 (NNS Brains)) (VP (VBD were) (VP (VBN embedded) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN gelatin)))))) (, ,) (CC and) (S (NP-SBJ-2 (NML (CD 35) (HYPH -) (NN μm)) (JJ sagittal) (NNS sections)) (VP (VBD were) (VP (VBN cut) (NP-2 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (VBG sliding) (NN microtome) (PRN (-LRB- -LRB-) (NP (NP (NNP NeuroScience) (NNP Associates)) (, ,) (NP-ADV (NN http://www.neuroscienceassociates.com))) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Sections)) (PP (IN from) (NP (UCP (NML (JJ wild) (HYPH -) (NN type)) (, ,) (NML (NN heterozygote)) (, ,) (CC and) (ADJP (JJ homozygous))) (NNS brains)))) (VP (VBD were) (VP (VBN placed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN MultiBrain) (NN template))))) (. .)) )
( (S (NP-SBJ-1 (NNS Sections)) (VP (VBD were) (VP (VBN washed) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (QP (CD 1) (SYM ×)) (NN PBS))) (PP-TMP (RB prior) (PP (IN to) (NP (NP (CD 1) (NN h)) (PP (IN of) (NP (NP (NN incubation)) (PP (IN in) (NP (NP (NN block) (NN solution)) (VP (VBG containing) (NP (NP (QP (CD 1) (SYM ×)) (NN PBS)) (PP (IN with) (NP (NP (NML (CD 20) (NN %)) (JJ normal) (NN goat) (NN serum)) (CC and) (NP (NML (CD 0.3) (NN %)) (NN Triton) (NN X) (HYPH -) (CD 100) (PRN (-LRB- -LRB-) (NP (NN pH) (CD 7.4)) (-RRB- -RRB-)))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Sections)) (VP (VBD were) (VP (VBN incubated) (NP-1 (-NONE- *)) (ADVP-TMP (RB overnight)) (PP-MNR (IN at) (NP (CD 4) (NN °C))) (PP-MNR (IN in) (NP (NP (JJ primary) (NNS antibodies)) (: :) (NP (NP (NP (NN affinity) (VBN purified) (JJ polyclonal) (NN Itpr1) (NN antibody) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM :) (NP (CD 2,000)))) (, ,) (NP (NP (NNP Chemicon) (NNP International)) (, ,) (NP-ADV (NN http://www.chemicon.com))) (-RRB- -RRB-))) (CC and) (NP (JJ monoclonal) (JJ anti-Calb1) (NN antibody) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM :) (NP (CD 6,000)))) (, ,) (NP (NP (NNP Sigma) (HYPH -) (NNP Aldrich)) (, ,) (NP-ADV (NN http://www.sigmaaldrich.com))) (-RRB- -RRB-)))) (VP (VBN diluted) (NP (-NONE- *)) (PP-MNR (IN in) (NP (NN carrier) (NN solution))))))))) (. .)) )
( (S (PP-TMP (VBG Following) (NP (NP (JJ extensive) (NNS washes)) (-LRB- -LRB-) (PP (IN in) (NP (NP (CD 6.0) (NN ml)) (PP (IN of) (NP (NN PBS))))) (PRN (, ,) (NP-TMP (CD three) (NNS times)) (-RRB- -RRB-)))) (, ,) (NP-SBJ-1 (NNS sections)) (VP (VBD were) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (JJ appropriate) (JJ secondary) (NNS antibodies) (PRN (-LRB- -LRB-) (NP (NP (NML (NNP Alexa) (NNP Fluor) (CD 555)) (NN goat) (JJ anti-rabbit) (NN IgG)) (CC and) (NP (NML (NNP Alexa) (NNP Fluor) (CD 488)) (NN goat) (JJ anti-mouse) (NN IgG) (PRN (-LRB- [) (NP (NP (NNP Invitrogen)) (, ,) (NP-ADV (NN http://www.invitrogen.com))) (-RRB- ])))) (-RRB- -RRB-)))) (PP-TMP (IN for) (NP (CD 1) (NN h))) (PP-MNR (IN at) (NP (NN room) (NN temperature))))) (. .)) )
( (S (NP-SBJ-1 (NNS Sections)) (VP (VBD were) (VP (VP (VBN washed) (NP-1 (-NONE- *))) (CC and) (VP (VBN mounted) (NP-1 (-NONE- *)) (PP-MNR (IN on) (NP (NN glass) (NNS slides))) (PP-MNR (IN in) (NP (NP (DT a) (VBN buffered) (NN medium)) (VP (VBG containing) (NP (NN Mowiol) (PRN (-LRB- -LRB-) (NP (NP (NNP Calbiochem)) (, ,) (NP-ADV (NN http://www.emdbiosciences.com))) (-RRB- -RRB-)))))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP (RBR earlier))))) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ-1 (NNS Sections)) (VP (VBD were) (VP (VBN imaged) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (NN laser) (VBG scanning) (JJ confocal) (NN microscope) (PRN (-LRB- -LRB-) (NP (NN LSM) (CD 510)) (: ;) (NP (NP (NNP Zeiss)) (, ,) (NP-ADV (NN http://www.zeiss.com))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NN Imaging) (NNS parameters) (PRN (-LRB- -LRB-) (NP (NP (NN pinhole)) (, ,) (NP (NN detector) (NN gain)) (, ,) (NP (NN laser) (NN power))) (-RRB- -RRB-))) (VP (VP (VBD were) (VP (VBN optimized) (NP-1 (-NONE- *)))) (, ,) (CC and) (VP (VBD were) (VP (VBN kept) (NP-1 (-NONE- *)) (S-CLR (NP-SBJ-1 (-NONE- *PRO*)) (ADJP-PRD (JJ constant))) (PP (IN for) (NP (DT the) (UCP (NML (JJ wild) (HYPH -) (NN type)) (, ,) (ADJP (JJ heterozygous)) (, ,) (CC and) (ADJP (JJ homozygous))) (NN mutant) (NNS brains)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Specificity)) (PP (IN of) (NP (DT the) (NN Itpr1) (NNS antibodies)))) (VP (VBD was) (VP (VBN verified) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN preabsorption) (NN control) (NNS experiments))))) (. .)) )
( (S (NP-SBJ-1 (NN Antibody) (NNS dilutions)) (VP (VBD were) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 24) (NN h))) (PP-MNR (IN at) (NP (CD 4) (NN °C))) (PP-MNR (IN with) (NP (DT the) (VBG immunizing) (NN peptide))))) (. .)) )
( (S (NP-SBJ-1 (NN Tissue) (NNS sections)) (VP (VBD were) (VP (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT the) (VBN preabsorbed) (NNS antibodies)))) (CC and) (VP (VBN processed) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP (RB above)))))))) (. .)) )
( (S (PP (IN Under) (NP (DT these) (NNS conditions))) (, ,) (NP-SBJ-1 (NP (DT no) (NN staining)) (PP (IN above) (NP (NN autofluorescence)))) (VP (VBD was) (VP (VBN detected) (NP-1 (-NONE- *)))) (. .)) )
( (HEADING (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (NN ITPR1)) (PP-LOC (IN in) (NP (NN SCA15) (NNS patients))))) (. .))) )
( (S (NP-SBJ-1 (NN DNA)) (VP (VBD was) (VP (VBN extracted) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NN EBV) (VBN immortalized) (NNS lymphocytes)) (, ,) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NN family) (NNS members)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (VBG coding) (NNS exons)) (CC and) (NP (NP (QP (RB at) (RBS least) (CD 50)) (NN bp)) (PP (IN of) (NP (NP (VBG flanking) (NNS introns)) (PP (IN of) (NP (NN ITPR1))))))) (VP (VBD were) (VP (VP (NN PCR) (VBN amplified) (NP-1 (-NONE- *))) (CC and) (VP (VBN sequenced) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NN dye) (HYPH -) (NN terminator)) (NN sequencing) (PRN (-LRB- -LRB-) (NP (NNP BigDye) (NN version) (CD 3.1)) (: ;) (NP (NP (NNP Applied) (NNP Biosystems)) (, ,) (NP-ADV (NN http://www.appliedbiosystems.com))) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ-1 (NN Sequence) (NNS reactions)) (VP (VBD were) (VP (VBN run) (NP-1 (-NONE- *)) (PP-MNR (IN on) (NP (DT an) (NN ABI3730XP) (VBN automated) (NN sequencer))) (PP-MNR (IN as) (PP (IN per) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS instructions) (PRN (-LRB- -LRB-) (NP (NNP Applied) (NNP Biosystems)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN analysis)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT all) (CD three) (VBN affected) (NN family) (NNS members)) (SBAR (WHPP-2 (IN for) (WHNP (WP whom))) (S (NP-SBJ (JJ genomic) (NN DNA)) (VP (VBD was) (ADJP-PRD (JJ available)) (PP-2 (-NONE- *T*))))) (PRN (-LRB- -LRB-) (NP (NNS members) (NML (CD 6) (, ,) (CD 7) (, ,) (CC and) (CD 19))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (NP (NN Primer) (NNS sequences)) (CC and) (NP (NNS conditions))) (VP (VBP are) (ADJP-PRD (JJ available)) (PP (IN upon) (NP (NN request)))) (. .)) )
( (S (NP-SBJ-1 (NN Sequence) (NNS data)) (VP (VBD were) (VP (VBN analyzed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NNP Sequencher) (PRN (-LRB- -LRB-) (NP (NP (NML (NNP Gene) (NNPS Codes)) (NNP Corporation)) (, ,) (NP-ADV (NN http://www.genecodes.com))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (NN Genome) (HYPH -) (JJ wide)) (NN SNP) (NN genotyping)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NNP Infinium) (NN HumanHap550) (NN SNP)) (NN genotyping) (NNS chips)) (PP-MNR (IN as) (PP (IN per) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NN protocol) (PRN (-LRB- -LRB-) (NP (NP (NNP Illumina)) (, ,) (NP-ADV (NN http://www.illumina.com))) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN product)) (VP (VBZ assays) (NP (CD 555,352) (JJ unique) (NNS SNPs))) (. .)) )
( (S (NP-SBJ-1 (NNS Data)) (VP (VBD were) (VP (VBN collected) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (NML (NNP Illumina) (NNP BeadStation)) (NN scanner)) (CC and) (NP (NML (NNS data) (NN collection)) (NN software))))))) (. .)) )
( (S (S (NP-SBJ-1 (NNS Genotypes)) (VP (VBD were) (VP (VBN produced) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (NN genotyping) (NN module)) (PP (IN of) (NP (NNP BeadStudio) (PRN (-LRB- -LRB-) (NP (NP (NN version) (CD 2.3.25)) (: ;) (NP (NNP Illumina))) (-RRB- -RRB-)))))))))) (, ,) (CC and) (S (NP-SBJ-2 (NP (NML (NN log) (NN R)) (NN ratio)) (CC and) (NP (NML (NN B) (NN allele)) (NN frequency))) (VP (VBD were) (VP (VBN visualized) (NP-2 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (NML (NN genome) (JJR viewer)) (NN tool)) (PP (IN within) (NP (DT this) (NN package))))))))) (. .)) )
( (S (PP-PRP (IN In) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB rule) (PRT (RP out)) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (VBN observed) (NN deletion)) (PP-LOC (IN within) (NP (NN ITPR1)))) (VP (VBD was) (NP-PRD (DT a) (JJ benign) (NN copy) (NN number) (NN variant))))))))))) (NP-SBJ (PRP we)) (VP (VBD examined) (NP (NP (NML (NML (NML (NN log) (NN R)) (NN ratio)) (CC and) (NML (NML (NN B) (NN allele)) (NN frequency))) (NNS metrics)) (PP (IN of) (NP (NP (NP (NN HumanHap550) (NN genotyping) (NNS data)) (PP-LOC (IN at) (NP (DT this) (NN locus))) (PP (IN from) (NP (NP (CD 577) (NNS individuals)) (PP (IN of) (NP (ADJP (JJ Northern) (JJ European)) (NN descent))) (PP (IN from) (NP (NP (NNP North) (NNP America)) (CC and) (NP (NNP Europe))))))) (, ,) (VP (VBN produced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (PRP us))) (PP (IN as) (NP (NP (DT a) (NN part)) (PP (IN of) (NP (DT an) (JJ ongoing) (NN study)))))))))) (. .)) )
( (S (PP (IN In) (NP (DT an) (NN attempt) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB narrow) (NP (NP (DT the) (JJ unknown) (NNS intervals)) (VP (VBG flanking) (NP (NP (DT the) (NN deletion)) (VP (VBN observed) (NP (-NONE- *)) (PP (IN in) (NP (NN family) (NN AUS1)))))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD designed) (NP (NP (NNS primers)) (PP (IN for) (NP (NP (CD 30) (NN PCR) (NNS amplifications)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD would) (VP (VB generate) (NP (VBG overlapping) (NNS fragments)) (PP (IN across) (NP (DT the) (CD two) (NN bordering) (NNS regions) (PRN (-LRB- -LRB-) (NP (NP (NP (NN primer) (NN sequence)) (CC and) (NP (NNS conditions))) (ADJP (JJ available) (PP (IN upon) (NP (NN request))))) (-RRB- -RRB-)))))))))))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBD were) (NP-PRD (NP (NP (CD ten) (NN primer) (NNS pairs)) (PP-LOC (IN in) (NP (DT the) (JJ telomeric) (NN flanking) (NN region)))) (CC and) (NP (NP (CD 20) (NNS pairs)) (PP-LOC (IN in) (NP (DT the) (JJ centromeric) (NN flanking) (NN region))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S3)) (-RRB- -RRB-))) (. .)) )
( (S (S (PP (IN On) (ADJP (JJ average))) (NP-SBJ (DT each) (NN product)) (VP (VBD was) (NP-PRD (NP (QP (SYM ~) (CD 750)) (NN bp)) (PP (IN in) (NP (NN size)))))) (, ,) (CC and) (S (NP-SBJ-1 (NNS amplifications)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (JJ genomic) (NN DNA)) (PP (IN from) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (CD three) (VBN affected) (NNS individuals) (PRN (-LRB- -LRB-) (NP (NN family) (NNS members) (NML (CD 6) (, ,) (CD 7) (, ,) (CC and) (CD 19))) (-RRB- -RRB-))))))))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (NML (NN Dye) (HYPH -) (NN terminator)) (NN sequencing)) (PP (IN of) (NP (DT each) (NN product)))) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (ADJP (JJ forward) (CC and) (JJ reverse)) (NNS primers)) (VP (VBN designed) (NP (-NONE- *)) (PP-PRP (IN for) (NP (NN amplification)))))))))) (: ;) (S (NP-SBJ-2 (NP (VBG running) (CC and) (NN analysis)) (PP (IN of) (NP (DT each) (NN fragment)))) (VP (VBD was) (VP (VBN performed) (NP-2 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN described) (NP-3 (-NONE- *)) (ADVP (RB above)))))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (NN Amplification)) (PP (IN of) (NP (NP (DT a) (NN fragment)) (PP (IN from) (NP (DT a) (JJ normal) (JJ diploid) (NN genome)))))) (VP (VBD was) (VP (VBN denoted) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN presence)) (PP (IN of) (NP (DT a) (JJ heterozygous) (NN polymorphism)))))))) (: ;) (S (NP-SBJ-2 (NP (NN amplification)) (PP (IN of) (NP (NP (DT a) (NN fragment)) (PP (IN from) (NP (NP (DT a) (NN region)) (PP (IN of) (NP (NP (DT the) (NN genome)) (VP (VBG harboring) (NP (DT a) (JJ heterozygous) (JJ genomic) (NN deletion)))))))))) (VP (VBD was) (VP (VBN inferred) (NP-2 (-NONE- *)) (SBAR-TMP (WHADVP-4 (WRB when)) (S (NP-SBJ-3 (NP (NN homozygosity)) (PP (IN for) (NP (NP (DT the) (JJ major) (NN allele)) (CC and) (NP (DT the) (JJ minor) (NN allele))))) (VP (VBD were) (VP (VBN noted) (NP-3 (-NONE- *)) (PP (IN among) (NP (DT the) (CD three) (VBN affected) (NN family) (NNS members))) (ADVP-TMP-4 (-NONE- *T*)) (PRN (-LRB- -LRB-) (S (ADVP (FW i.e.)) (, ,) (NP-SBJ (DT this)) (VP (VBZ is) (ADJP-PRD (JJ inconsistent) (PP (IN with) (NP (NP (JJ Mendelian) (NN inheritance)) (PP (IN in) (NP (NP (JJ related) (NNS individuals)) (VP (VBN known) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB share) (NP (DT a) (JJ common) (NN haplotype))))))))))))) (-RRB- -RRB-))))))))) (. .)) )
( (S (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG Using) (NP (DT the) (NNS data)) (PP (IN from) (NP (NP (DT the) (NNS experiments)) (VP (VBN described) (NP (-NONE- *)) (ADVP (RB above))))))) (NP-SBJ-1 (PRP we)) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB limit) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (NP (JJ unknown) (NNS regions)) (VP (VBG flanking) (NP (DT the) (NN deletion)))))) (PP (IN to) (NP (NP (NP (QP (SYM ~) (CD 4)) (NN kb)) (PP (IN on) (NP (DT the) (JJ telomeric) (NN side)))) (CC and) (NP (NP (CD 7) (NN kb)) (PP (IN on) (NP (DT the) (JJ centromeric) (NN side))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (DT All) (NNS combinations)) (PP (IN of) (NP (NP (JJ forward) (NNS primers)) (PP (IN from) (NP (DT the) (ADJP (RB newly) (VBN defined)) (NN region)))))) (VP (VBG flanking) (NP (DT the) (NN deletion)) (PP-LOC (IN on) (NP (DT the) (JJ telomeric) (NN side))) (PP (IN with) (NP (NP (NP (JJ reverse) (NNS primers)) (PP (IN from) (NP (DT the) (ADJP (RB newly) (VBN defined)) (NN region)))) (VP (VBG flanking) (NP (DT the) (NN deletion)) (PP-LOC (IN on) (NP (DT the) (JJ centromeric) (NN side)))))))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (NML (NN PCR) (NN amplification)) (NNS reactions)) (VP (VBN performed) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN DNA)) (PP (IN from) (NP (NP (DT the) (CD three) (VBN affected) (NN family) (NNS members)) (CC and) (NP (JJ single) (JJ unaffected) (NN family) (NNS members))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN experiment)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN in) (NP (DT an) (NN attempt) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VP (VB amplify) (PP (IN across) (NP (DT the) (VBN deleted) (NN fragment)))) (CC and) (VP (VB define) (NP (DT the) (JJ exact) (NN breakpoint)))))))))) (. .)) )
( (S (NP-SBJ-1 (DT A) (JJ single) (NN fragment)) (VP (VBD was) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (JJ third) (JJ forward) (NN primer)) (PP (IN from) (NP (DT the) (JJ telomeric) (NN side))) (PRN (-LRB- -LRB-) (NP (NN T3f) (NML (CD 5) (SYM ′)) (HYPH -) (NN TGAATGCTCAATTTTCCAGC) (HYPH -) (CD 3) (SYM ′)) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (DT the) (JJ 11th) (JJ reverse) (NN primer)) (PP (IN from) (NP (DT the) (JJ centromeric) (NN side))) (PRN (-LRB- -LRB-) (NP (NN C11r) (NML (CD 5) (SYM ′)) (HYPH -) (NN GGGAAAATGGATAGAGGGTG) (HYPH -) (CD 3) (SYM ′)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-2 (NP (DT The) (NN fragment)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (NP-PRD (NP (CD 953) (NN bp)) (PP (IN in) (NP (NN size)))))))) (, ,) (VP (VBD was) (VP (VBN sequenced) (NP-2 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VP (VBN described) (NP-3 (-NONE- *)) (ADVP (RB above))) (CC and) (VP (VBN compared) (NP-3 (-NONE- *)) (PP (IN to) (NP (NP (DT the) (JJ current) (NN build)) (PP (IN of) (NP (DT the) (JJ human) (NN genome))))))))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (DT A) (JJ similar) (NN series)) (PP (IN of) (NP (NNS experiments)))) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (NP (DT the) (NN deletion) (NNS breakpoints)) (PP (IN in) (NP (NNS families) (NML (NN H27) (CC and) (NN H33))))))))))) (: ;) (S (S (NP-SBJ-2 (PRP we)) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB amplify) (NP (DT a) (NML (CD 369) (HYPH -) (NN bp)) (NN PCR) (NN product)) (PP (IN across) (NP (NP (DT the) (NN breakpoint)) (VP (VBN found) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (VBN affected) (NNS members)) (PP (IN of) (NP (NN family) (NN H27)))))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NN primer) (NN pair)) (NP (NP (NML (NN H27) (HYPH -) (NN 11F)) (NML (CD 5) (SYM ′)) (HYPH -) (NN GACCTCAAGAAGGCATGAATAC) (HYPH -) (CD 3) (SYM ′)) (CC and) (NP (NML (NN H27) (HYPH -) (NN 3R)) (NML (CD 5) (SYM ′)) (HYPH -) (NN ATGGTGGCCAGGTACACAAG) (HYPH -) (CD 3) (SYM ′)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S4)) (-RRB- -RRB-)))))))))) (, ,) (CC but) (S (PP-TMP (IN to) (NP (NN date))) (NP-SBJ-3 (PRP we)) (VP (VBP have) (VP (VBN been) (ADJP-PRD (JJ unable) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (NP (DT the) (NN breakpoint)) (PP (IN in) (NP (NN family) (NN H33)))))))))))) (. .)) )
( (HEADING (NP (NP (NML (NNP Western) (NN blot)) (NN analysis)) (PP-LOC (IN in) (NP (NN SCA15) (NNS patients))) (. .))) )
( (S (S (NP-SBJ-2 (NP (NN EBV) (VBN immortalized) (NNS lymphoblasts)) (PP (IN from) (NP (NP (NP (CD three) (VBN affected) (NN family) (NNS members)) (SBAR (WHNP-1 (WP who)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP carry) (NP (DT the) (NN deletion)))))) (CC and) (NP (NP (CD one) (NN family) (NN member)) (PP (IN without) (NP (DT the) (NN mutation))))))) (VP (VBD were) (VP (VBN used) (NP-2 (-NONE- *)) (PP-MNR (IN as) (NP (NP (DT a) (ADJP (RB readily) (JJ accessible)) (NN source)) (PP (IN of) (NP (NN protein)))))))) (: ;) (S (NP-SBJ (DT all) (NNS samples)) (VP (VBD came) (PP (IN from) (NP (NP (NNS members)) (PP (IN of) (NP (NN family) (NN AUS1))))))) (. .)) )
( (S (NP-SBJ-1 (NN Protein) (NN extraction)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NN lysis) (NN buffer)) (VP (VBG containing) (NP (NP (QP (CD 1) (SYM ×)) (NN TBS)) (, ,) (NP (NML (CD 1) (NN %)) (NN Triton) (NN X) (HYPH -) (CD 100)) (, ,) (CC and) (NP (NP (DT a) (NN cocktail)) (PP (IN of) (NP (NN protease) (NNS inhibitors) (PRN (-LRB- -LRB-) (NP (NNP Roche)) (-RRB- -RRB-)))))))))) (PP-MNR (IN with) (NP (JJ overnight) (NN lysis))) (PP-MNR (IN at) (NP (QP (SYM −) (CD 80)) (NN °C))))) (. .)) )
( (S (NP-SBJ-1 (NNS Homogenates)) (VP (VBD were) (VP (VP (VBN diluted) (NP-1 (-NONE- *)) (ADVP (RB appropriately))) (, ,) (VP (VBN mixed) (NP-1 (-NONE- *)) (PP (IN with) (NP (QP (CD 4) (SYM ×)) (VBG reducing) (NN sample) (NN buffer)))) (, ,) (CC and) (VP (VBN loaded) (NP-1 (-NONE- *)) (PP (IN onto) (NP (NML (NML (CD 4) (NN %)) (PP (SYM –) (NP (CD 12) (NN %)))) (JJ precast) (NN gradient) (NNS gels) (PRN (-LRB- -LRB-) (NP (NP (NN NuPAGE)) (, ,) (NP (NNP Invitrogen))) (-RRB- -RRB-)))) (PP-PRP (IN for) (NP (NP (NN SDS) (HYPH -) (NN PAGE)) (CC and) (NP (NN immunoblotting))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NNS antibodies)) (PP (IN to) (NP (NP (NN ITPR1) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM :) (NP (CD 1,000)))) (-RRB- -RRB-))) (CC and) (NP (NN ACTB) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM :) (NP (CD 5,000)))) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN recommended) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NNS manufacturers)))))))) (. .)) )
( (HEADING (NP (JJ Supporting) (NN Information))) )
( (HEADING (NP (NN Figure) (NN S1))) )
( (HEADING (NP (NP (JJ Schematic)) (PP (IN of) (NP (NP (NN Genotyping) (NNS Results)) (PP (IN across) (NP (NN Mouse) (NN Chromosome) (CD 6))) (PP-LOC (IN in) (NP (VBN Affected) (NNS Mice))))))) )
( (CAPTION (S (S (NP-SBJ=1 (JJ Black) (NNS squares)) (VP (VBP are) (ADJP-PRD (JJ indicative) (PP (IN of) (NP=2 (DT a) (NML (NN C57BL) (HYPH /) (NN 6J)) (JJ homozygous) (NN genotype)))))) (: ;) (S (NP-SBJ=1 (ADJP (JJ light) (JJ grey)) (NNS squares)) (, ,) (NP=2 (DT a) (NML (NN 129x1) (HYPH /) (NN SvJ)) (JJ homozygous) (NN genotype))) (: ;) (S (NP-SBJ=1 (JJ grey) (NNS squares)) (, ,) (NP=2 (DT a) (NML (NN C57BL) (HYPH /) (NN 6J)) (NML (NN 129x1) (HYPH /) (NN SvJ)) (JJ heterozygous) (NN genotype))) (: ;) (S (NP-SBJ=1 (JJ white) (NNS squares)) (, ,) (NP=2 (JJ undetermined) (NN genotype))) (. .))) )
( (CAPTION (S (S (NP-SBJ (DT The) (JJ black) (NN box)) (VP (VBZ bounds) (NP (NP (NP (DT a) (NN region)) (PP (IN of) (NP (JJ homozygous) (NML (NN 129x1) (HYPH /) (NN SvJ)) (NNS genotypes)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP segregate) (PP (IN with) (NP (NN disease))))))))) (: ;) (S (ADVP (RB thus)) (, ,) (NP-SBJ-2 (DT the) (JJ critical) (NN region)) (VP (VBD was) (VP (VBN determined) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (PP-LOC-PRD (IN between) (NP (NNS markers) (NML (NML (NN D6Mit37)) (CC and) (NML (NN 44.MMHAP85FLG5))))))))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 10) (NN MB)) (NN TIF) (-RRB- -RRB-))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP (RB here)) (PP-PRP (IN for) (NP (JJ additional) (NNS data) (NN file))) (. .)))) )
( (HEADING (NP (NN Figure) (NN S2))) )
( (HEADING (NP (NP (NN Sequence)) (PP (IN of) (NP (NP (NN Exon) (CD 36)) (PP (IN of) (NP (NP (NN Itpr1)) (PP (IN from) (NP (CD Four) (NNS Mice))))))))) )
( (CAPTION (NP (NP (DT A) (NML (JJ wild) (HYPH -) (NN type)) (JJ homozygous) (NML (NN C57BL) (HYPH /) (NN 6J)) (NN mouse) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (, ,) (NP (DT a) (NML (JJ wild) (HYPH -) (NN type)) (JJ homozygous) (NML (NN 129x1) (HYPH /) (NN SvJ)) (NN mouse) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-))) (, ,) (NP (NP (DT an) (VBN affected) (NN 129x1B6) (NNS mice)) (ADJP (JJ homozygous) (PP (IN for) (NP (DT the) (NML (CD 18) (HYPH -) (NN bp)) (NN deletion) (NN mutation)))) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (DT an) (JJ unaffected) (NN mouse)) (ADJP (JJ heterozygous) (PP (IN for) (NP (DT the) (NML (CD 18) (HYPH -) (NN bp)) (NN deletion) (NN mutation)))) (PRN (-LRB- -LRB-) (NP (NN D)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (VBN deleted) (NNS nucleotides)) (VP (VBP are) (VP (VBN bounded) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT a) (JJ green) (NN box))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 5.1) (NN MB)) (NN TIF) (-RRB- -RRB-))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP (RB here)) (PP-PRP (IN for) (NP (JJ additional) (NNS data) (NN file)))) (. .))) )
( (HEADING (NP (NN Figure) (NN S3))) )
( (HEADING (NP (NP (JJ Additional) (NNS Families)) (VP (VBG Harboring) (NP (NN Deletion)) (PP-LOC (IN at) (NP (DT the) (NN SCA15) (NN Locus)))))) )
( (CAPTION (NP (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN Family) (NN H33)) (: ;) (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NN family) (NN H27)) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Upper) (NN panel)) (VP (VBZ shows) (NP (NP (NML (NML (NML (NN log) (NN R)) (NN ratio)) (CC and) (NML (NML (NN B) (NN allele)) (NN frequency))) (NNS metrics)) (VP (VBN generated) (NP (-NONE- *)) (PP-MNR (IN from) (NP (NP (NML (NNP Infinium) (NN HumanHap550)) (NNS arrays)) (PP (IN for) (NP (NP (DT an) (VBN affected) (NN family) (NN member)) (PP (IN from) (NP (DT each) (NN family)))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NML (NN Log) (NN R)) (NN ratio)) (VP (VP (VBZ is) (NP-PRD (NP (DT the) (NN ratio)) (PP (IN of) (NP (VBN normalized) (, ,) (VBN observed) (NN R))) (PP (IN to) (NP (JJ expected) (NN R))) (PP (IN for) (NP (DT each) (NN SNP)))) (PRN (-LRB- -LRB-) (S (NP-SBJ (DT each) (NN SNP)) (VP (VBZ is) (NP-PRD (DT a) (JJ blue) (NN dot)))) (-RRB- -RRB-))) (CC and) (VP (ADVP (RB thus)) (VBZ serves) (PP (IN as) (NP (NP (DT a) (NN surrogate)) (PP (IN of) (NP (NN copy) (NN number))))) (PP-LOC (IN at) (NP (DT each) (NN locus))))) (. .))) )
( (CAPTION (S (NP-SBJ (NML (NN B) (NN allele)) (NN frequency)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN measure)) (PP (IN of) (NP (NP (DT the) (NN number) (SBAR-3 (-NONE- *ICH*))) (PP (IN of) (NP (NNS times))) (SBAR-3 (-NONE- *0*) (S (NP-SBJ-1 (DT the) (NML (NN A) (CC or) (NN B)) (NNS alleles)) (VP (VBP are) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN at) (NP (DT each) (NN locus)))))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (DT each) (NN SNP)) (VP (VBZ is) (VP (VBN denoted) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (DT a) (JJ blue) (NN dot)))))) (-RRB- -RRB-))) (. .))) )
( (S (ADVP (RB Thus)) (, ,) (S (S (NP-SBJ (NP (NNS SNPs)) (PP (IN with) (NP (NP (DT a) (NML (NN B) (NN allele)) (NN frequency)) (PP (IN of) (NP (CD one)))))) (VP (VBP are) (NP-PRD (JJ apparent) (NML (NN B) (HYPH /) (NN B)) (NNS homozygotes)))) (, ,) (S (NP-SBJ (NP (NNS SNPs)) (PP (IN with) (NP (NP (DT a) (NML (NN B) (NN allele)) (NN frequency)) (PP (IN of) (NP (CD 0.5)))))) (VP (VBP are) (NP-PRD (JJ apparent) (NML (NN A) (HYPH /) (NN B)) (NNS heterozygotes)))) (, ,) (CC and) (S (NP-SBJ (NP (DT those)) (PP (IN with) (NP (NP (DT a) (NML (NN B) (NN allele)) (NN frequency)) (PP (IN of) (NP (CD zero)))))) (VP (VBP are) (NP-PRD (JJ apparent) (NML (NN A) (HYPH /) (NN A)) (NNS homozygotes))))) (. .)) )
( (CAPTION (S (NP-SBJ (DT These) (NNS plots)) (VP (VBP show) (NP (NP (NP (DT a) (JJ contiguous) (NN region)) (ADJP (ADJP (NP (QP (SYM ~) (CD 310)) (NN kb)) (JJ long) (PRN (-LRB- -LRB-) (NP (NN family) (NN H33)) (-RRB- -RRB-))) (CC and) (ADJP (NP (QP (SYM ~) (CD 350)) (NN kb)) (JJ long) (PRN (-LRB- -LRB-) (NP (NN family) (NN H27)) (-RRB- -RRB-))))) (PP (IN with) (NP (NP (NP (VBN decreased) (NN copy) (NN number)) (CC and) (NP (JJ apparent) (NN homozygosity))) (ADJP (JJ indicative) (PP (IN of) (NP (DT a) (JJ genomic) (NN deletion)))) (PRN (-LRB- -LRB-) (NP (VBN shaded) (NN grey)) (-RRB- -RRB-)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NNS pedigrees)) (ADVP (RB below))) (VP (VBP show) (NP (NP (NP (DT the) (JJ available) (NN family) (NNS members)) (VP (VBN assayed) (NP (-NONE- *)) (PP (IN for) (NP (DT these) (NNS deletions))))) (, ,) (SBAR (SBAR (WHNP-1 (NP (DT all)) (WHPP (IN of) (WHNP (WP whom)))) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (VP (VBN affected) (NP-1 (-NONE- *)))))) (CC and) (SBAR (WHNP-2 (NP (DT all)) (WHPP (IN of) (WHNP (WP whom)))) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD carried) (NP (DT a) (NN deletion)) (PP-LOC (IN at) (NP (DT this) (NN locus))))))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 6.8) (NN MB)) (NN TIF) (-RRB- -RRB-))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP (RB here)) (PP-PRP (IN for) (NP (JJ additional) (NNS data) (NN file)))) (. .))) )
( (HEADING (NP (NN Figure) (NN S4))) )
( (HEADING (NP (NP (VBN Deleted) (NNS Regions)) (VP (VBN Identified) (NP (-NONE- *)) (PP (IN in) (NP (NP (NNS Families)) (NP (NN AUS1) (CC and) (NN H27))))))) )
( (CAPTION (NP (PRN (-LRB- -LRB-) (NP (NN Top)) (-RRB- -RRB-)) (NP (NN Family) (NN AUS1)) (: ;) (NP (NP (NN sequence)) (PP (IN from) (NP (NP (DT the) (NN PCR) (NN product)) (VP (VBN generated) (NP (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NP (NNS primers)) (NP (NN T3f) (CC and) (NN C11r))) (PP (IN from) (NP (NP (JJ genomic) (NN DNA)) (PP (IN from) (NP (DT an) (VBN affected) (NN family) (NN member)))))))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (JJ Red) (NN arrowhead)) (VP (VBZ denotes) (NP (DT the) (NN deletion) (NN breakpoint)))) (: ;) (S (NP-SBJ (DT the) (NN deletion)) (VP (VBZ is) (NP-PRD (NP (CD 201,510) (NN bp)) (PP (IN in) (NP (NN length)))))) (. .))) )
( (CAPTION (NP (PRN (-LRB- -LRB-) (NP (NN Bottom)) (-RRB- -RRB-)) (NP (NN Family) (NN H27)) (: ;) (NP (NP (NN sequence)) (VP (VBG flanking) (NP (VBN deleted) (NN region)))) (. .))) )
( (CAPTION (S (S (NP-SBJ (JJ Green) (NN font)) (VP (VBZ indicates) (NP (NP (NNS nucleotides)) (ADJP (JJ telomeric) (PP (IN to) (NP (DT the) (NN deletion))))))) (: ;) (S (NP-SBJ (JJ blue) (NN font)) (VP (VBZ indicates) (NP (NP (NNS nucleotides)) (ADJP (JJ centromeric) (PP (IN to) (NP (DT the) (NN deletion))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NN deletion)) (VP (VBZ is) (NP-PRD (NP (CD 344,408) (NN bp)) (PP (IN in) (NP (NN length))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Basepair) (NNS positions)) (VP (VBP are) (VP (VBN based) (NP-1 (-NONE- *)) (PP (IN on) (NP (NN NCBI) (NML (NN genome) (VB build) (CD 36)) (NN reference) (NN assembly))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 876) (NN KB)) (NN MB) (NN TIF) (-RRB- -RRB-) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP (RB here)) (PP-PRP (IN for) (NP (JJ additional) (NNS data) (NN file)))) (. .))) )
( (HEADING (NP (NN Accession) (NNS Numbers))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NML (NN OMIM) (PRN (-LRB- -LRB-) (NP (NN http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM)) (-RRB- -RRB-))) (NN accession) (NN number)) (PP (IN for) (NP (NN SUMF1)))) (VP (VBZ is) (NP-PRD (CD 607939))) (. .))) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ (PRP We)) (VP (VBP thank) (NP (DT the) (NN SCA15) (NN family) (NNS members)) (PP-PRP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG participating) (PP (IN in) (NP (DT this) (NN study))))))) (. .)) )
( (HEADING (NP (NNS Abbreviations))) )
( (NP (NP (NN EBV)) (: -) (NP (NML (NNP Epstein) (HYPH -) (NNP Barr)) (NN virus))) )
( (NP (NP (NN SCA) (-LRB- [) (NN number) (-RRB- ])) (: -) (NP (JJ spinocerebellar) (NN ataxia) (-LRB- [) (NN number) (-RRB- ]))) )
( (NP (NP (NN SNP)) (: -) (NP (NML (JJ single) (NN nucleotide)) (NN polymorphism))) )
( (HEADING (NP (NNS Figures) (CC and) (NNS Tables))) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (HEADING (NP (NP (NP (NN Immunohistochemistry)) (CC and) (NP (NML (NNP Western) (NN Blot)) (NN Analysis))) (PP (IN of) (NP (NP (NN ITPR1) (NN Protein) (NNS Levels)) (PP-LOC (IN in) (NP (NN Mouse) (NN Cerebellum))))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (SYM –) (LS F) (-RRB- -RRB-)) (NP (NN Immunohistochemistry)) (PP (IN of) (NP (NP (NN cerebellum)) (PP (IN from) (NP (NP (DT a) (NML (JJ wild) (HYPH -) (NN type)) (NN mouse) (PRN (-LRB- -LRB-) (NP (NN A) (CC and) (NN D)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN mouse)) (ADJP (JJ heterozygous) (PP (IN for) (NP (DT the) (NN Itpr1) (NML (CD 18) (HYPH -) (NN bp)) (NN deletion)))) (PRN (-LRB- -LRB-) (NP (NN B) (CC and) (NN E)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (DT a) (NN mouse)) (ADJP (JJ homozygous) (PP (IN for) (NP (DT the) (NML (CD 18) (HYPH -) (NN bp)) (NN Itpr1) (NN deletion)))) (PRN (-LRB- -LRB-) (NP (NN C) (CC and) (NN F)) (-RRB- -RRB-))))))) (. .))) )
( (CAPTION (NP (NP (LST (-LRB- -LRB-) (LS A) (SYM –) (LS C) (-RRB- -RRB-)) (NP (NN Immunohistochemistry)) (VP (VBG using) (NP (JJ polyclonal) (NN Itpr1) (JJ anti-rabbit) (NN antibody) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM :) (NP (CD 2,000)))) (: ;) (NP (NNP Alexa) (NNP Fluor) (CD 555)) (-RRB- -RRB-))))) (: ;) (NP (LST (-LRB- -LRB-) (LS D) (SYM –) (LS F) (-RRB- -RRB-)) (NP (NN immunohistochemistry)) (VP (VBG using) (NP (JJ monoclonal) (NN Calb1) (JJ anti-mouse) (NN antibody) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM :) (NP (CD 6,000)))) (: ;) (NP (NNP Alexa) (NNP Fluor) (CD 488)) (-RRB- -RRB-))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Scale) (NNS bars)) (VP (VBP denote) (NP (CD 100) (NN μm))) (. .))) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-1 (-NONE- *))))) (, ,) (NP-SBJ-2 (NN Iptr1)) (VP (VBZ is) (ADVP (RB highly)) (VP (VBN expressed) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NNP Purkinje) (NNS cells))))) (. .)) )
( (S (ADVP (RB Notably)) (, ,) (NP-SBJ-1 (EX there)) (VP (VBZ appears) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (NP (VBN decreased) (NN immunoreactivity)) (PP (IN to) (NP (NN Itpr1)))) (PP-LOC (IN in) (NP (DT the) (ADJP (JJ heterozygous) (CC and) (JJ homozygous)) (NN mutant) (NNS mice))))))) (. .)) )
( (CAPTION (FRAG (LST (-LRB- -LRB-) (LS G) (-RRB- -RRB-)) (NP (NP (NNP Western) (NN blot)) (VP (VBN performed) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB examine) (NP (NN Itpr1) (NNS levels)) (PP-LOC (IN in) (NP (NP (JJ whole) (NN brain)) (PP (IN from) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (, ,) (NML (NN Itpr1wt) (HYPH /) (NN Δ18)) (, ,) (CC and) (NML (NN Itpr1Δ18) (HYPH /) (NN Δ18))) (NNS mice)))))))))) (: ;) (S (NP-SBJ (DT this)) (ADVP (RB clearly)) (VP (VBZ shows) (NP (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NN Itpr1))) (PP-LOC (IN in) (NP (NP (NN brain) (NN tissue)) (PP (IN from) (NP (NML (NN Itpr1wt) (HYPH /) (NN Δ18)) (NNS mice)))))) (CC and) (NP (NP (DT a) (JJR greater) (NN reduction)) (PP (IN of) (NP (NN Itpr1))) (PP-LOC (IN in) (NP (NML (NN Itpr1Δ18) (HYPH /) (NN Δ18)) (NNS mice))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (HEADING (NP (NP (NNS Metrics)) (VP (VBN Derived) (NP (-NONE- *)) (PP (IN from) (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (NN DNA)) (PP (IN from) (NP (VBN Affected) (NN Family) (NN Member) (CD 7))))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG Using) (NP (NML (NNP Illumina) (NNP Infinium) (NNP HumanHap550)) (NN Genotyping) (NNS Chips))))))) )
( (CAPTION (S (NP-SBJ (DT The) (ADJP (JJ upper) (CC and) (JJ lower)) (NNS plots)) (VP (VBP are) (NP-PRD (NP (NML (NN log) (NN R)) (NN ratio)) (CC and) (NP (NML (NN B) (NN allele)) (NN frequency))) (, ,) (ADVP (RB respectively)) (, ,) (PP-LOC (IN at) (NP (NP (DT an) (NML (QP (SYM ~) (CD 800)) (HYPH -) (NN kb)) (NN segment)) (PP (IN on) (NP (NP (DT the) (NN p) (NN arm)) (PP (IN of) (NP (NN Chromosome) (CD 3)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NML (NN Log) (NN R)) (NN ratio)) (VP (VP (VBZ is) (NP-PRD (NP (DT the) (NN ratio)) (PP (IN of) (NP (VBN normalized) (, ,) (VBN observed) (NN R))) (PP (IN to) (NP (VBN expected) (NN R))) (PP (IN for) (NP (DT each) (NN SNP))) (PRN (-LRB- -LRB-) (S (NP-SBJ (DT each) (NN SNP)) (VP (VBZ is) (NP-PRD (DT a) (JJ blue) (NN dot)))) (-RRB- -RRB-)))) (CC and) (VP (ADVP (RB thus)) (VBZ serves) (PP (IN as) (NP (NP (DT a) (NN surrogate)) (PP (IN of) (NP (NN copy) (NN number))))) (PP-LOC (IN at) (NP (DT each) (NN locus))))) (. .))) )
( (CAPTION (S (NP-SBJ (NML (NN B) (NN allele)) (NN frequency)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN measure)) (PP (IN of) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS times)) (SBAR (WHADVP-3 (-NONE- *0*)) (S (NP-SBJ-1 (DT the) (NML (NN A) (CC or) (NN B)) (NNS alleles)) (VP (VBP are) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN at) (NP (DT each) (NN locus))) (ADVP-TMP-3 (-NONE- *T*))))))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (DT each) (NN SNP)) (VP (VBZ is) (VP (VBN denoted) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (DT a) (JJ blue) (NN dot)))))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (S (ADVP (RB Thus)) (, ,) (S (S (NP-SBJ (NP (NNS SNPs)) (PP (IN with) (NP (NP (DT a) (NML (NN B) (NN allele)) (NN frequency)) (PP (IN of) (NP (CD one)))))) (VP (VBP are) (NP-PRD (JJ apparent) (NML (NN B) (HYPH /) (NN B)) (NNS homozygotes)))) (, ,) (S (NP-SBJ (NP (NNS SNPs)) (PP (IN with) (NP (NP (DT a) (NML (NN B) (NN allele)) (NN frequency)) (PP (IN of) (NP (CD 0.5)))))) (VP (VBP are) (NP-PRD (JJ apparent) (NML (NN A) (HYPH /) (NN B)) (NNS heterozygotes)))))) (, ,) (CC and) (S (NP-SBJ (NP (DT those)) (PP (IN with) (NP (NP (DT a) (NML (NN B) (NN allele)) (NN frequency)) (PP (IN of) (NP (CD zero)))))) (VP (VBP are) (NP-PRD (JJ apparent) (NML (NN A) (HYPH /) (NN A)) (NNS homozygotes)))) (. .))) )
( (CAPTION (S (ADVP (RB Clearly)) (, ,) (NP-SBJ (DT these) (NNS plots)) (VP (VBP show) (NP (NP (NP (NP (DT a) (JJ contiguous) (NN region)) (ADJP (NP (QP (SYM ~) (CD 200)) (NN kb)) (JJ long))) (PP (IN with) (NP (NP (VBN decreased) (NN copy) (NN number)) (CC and) (NP (JJ apparent) (NN homozygosity))))) (-LRB- -LRB-) (VP (VBN bounded) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT a) (JJ red) (NN box)))))) (-RRB- -RRB-) (. .))) )
( (CAPTION (S (SBAR-ADV (IN As) (S (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN demonstrated) (ADVP-TMP (RB previously)))))) (, ,) (NP-SBJ (DT this)) (VP (VBZ is) (ADJP-PRD (JJ indicative) (PP (IN of) (NP (DT a) (JJ heterozygous) (JJ genomic) (NN deletion)))) (PRN (-LRB- [) (NP (CD 15)) (-RRB- ]))) (. .))) )
( (CAPTION (SINV (PP-TPC-1 (IN Below) (NP (DT these) (NNS plots))) (VP (VBZ is) (PP-PRD-1 (-NONE- *T*))) (NP-SBJ (NP (DT a) (NN schematic)) (PP (IN of) (NP (NP (NP (DT the) (CD two) (VBN known) (NNS genes)) (VP (VBN affected) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT this) (NN deletion))))) (, ,) (NP (NN ITPR1) (CC and) (NN SUMF1))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (HEADING (NP (NP (NN Mutation) (NN Analysis)) (PP (IN in) (NP (DT the) (JJ Australian) (NN SCA15) (NN Family))))) )
( (CAPTION (NP (PRN (-LRB- -LRB-) (NP (NN Top)) (-RRB- -RRB-)) (NP (NN Pedigree)) (PP (IN of) (NP (NN kindred))) (. .))) )
( (CAPTION (S (S (NP-SBJ=1 (VBN Filled) (NNS symbols)) (VP (VBP denote) (NP=2 (VBN affected) (NNS individuals)))) (: ;) (S (NP-SBJ=1 (JJ open) (NNS symbols)) (, ,) (NP=2 (JJ unaffected) (NNS individuals))) (: ;) (S (NP-SBJ (JJ grey) (NN symbol)) (VP (VBZ denotes) (NP (JJ unknown) (NN disease) (NN status)))) (: ;) (S (NP-SBJ (NML (NN bulls) (HYPH -) (NN eye)) (NN symbol)) (VP (VBZ denotes) (NP (JJ obligate) (NN carrier)))) (. .))) )
( (CAPTION (NP (NP (NP (NN w) (HYPH /) (NN w)) (, ,) (NP (NP (JJ wild) (HYPH -) (NN type)) (PP (IN at) (NP (NN ITPR1))))) (: ;) (NP (NP (NN w) (HYPH /) (NN m)) (, ,) (NP (NP (JJ heterozygous) (NN carrier)) (PP (IN of) (NP (DT the) (NN ITPR1) (NN deletion))))) (. .))) )
( (CAPTION (NP (PRN (-LRB- -LRB-) (NP (NN Middle)) (-RRB- -RRB-)) (NP (JJ Schematic)) (PP (IN of) (NP (NP (NN primer) (NNS pairs)) (VP (VBN used) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB narrow) (NP (NP (DT the) (JJ unknown) (NNS regions)) (PP-LOC (IN between) (NP (NP (VBN known) (VBN deleted) (NN sequence)) (CC and) (NP (VBN known) (JJ diploid) (NN sequence))))) (PP-LOC (IN at) (NP (DT the) (NN SCA15) (NN locus))))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (CD Nine) (NN primer) (NNS pairs) (PRN (-LRB- -LRB-) (NP (NP (NN T1)) (PP (SYM –) (NP (NN T9)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB amplify) (PP (IN across) (NP (NP (DT the) (JJ unknown) (NN region)) (ADJP (JJ telomeric) (PP (IN to) (NP (DT the) (VBN known) (VBN deleted) (NN region)))))))))))) (: ;) (S (NP-SBJ-2 (CD 19) (NN primer) (NNS pairs) (PRN (-LRB- -LRB-) (NP (NP (NN C1)) (PP (SYM –) (NP (NN C19)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN used) (NP-2 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB amplify) (PP (IN across) (NP (DT the) (JJ unknown) (NN region) (JJ centromeric))) (PP (IN to) (NP (DT the) (VBN known) (VBN deleted) (NN region))))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT All) (NNS PCRs)) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP-LOC (IN in) (NP (DT the) (CD three) (VBN affected) (NN family) (NNS members))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (NP (NN Analysis)) (PP (IN of) (NP (DT these) (NNS data)))) (VP (VBD narrowed) (NP (DT the) (JJ unknown) (NN region)))) (, ,) (CC and) (S (ADVP (RB ultimately)) (NP-SBJ-1 (PRP we)) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB use) (NP (NP (NN primer)) (NP (NN T3f) (CC and) (NN C11r))) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB amplify) (PP-LOC (IN across) (NP (DT the) (NN deletion) (NN breakpoint))) (PP-LOC (IN in) (NP (DT the) (CD three) (VBN affected) (NN family) (NNS members))) (, ,) (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG producing) (NP (NP (DT a) (NN fragment)) (PP (IN of) (NP (CD 953) (NN bp)))) (PP-LOC (IN in) (NP (VBN affected) (NNS individuals)))))))))))))) (. .))) )
( (CAPTION (NP (PRN (-LRB- -LRB-) (NP (NN Bottom)) (-RRB- -RRB-)) (NP (NN Gel)) (VP (VBG showing) (NP (NP (NN amplification) (NN product)) (VP (VBG using) (NP (NP (NP (NN primer) (NN pair)) (NP (NN T3f) (CC and) (NN C11r))) (PP (PP (IN from) (NP (VBN affected) (NN pedigree) (NNS members) (NML (CD 6) (, ,) (CD 7) (, ,) (CC and) (CD 19)))) (: ;) (PP-LOC (IN in) (NP (NP (NN pedigree) (NN member) (CD 23)) (, ,) (PP (IN with) (NP (JJ unknown) (NML (NN disease) (NN affection)) (NN status))))) (: ;) (PP-LOC (IN in) (NP (DT a) (ADJP (RB neurologically) (JJ normal)) (NN control) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-)))) (: ;) (CC and) (PP-LOC (IN in) (NP (DT a) (NML (DT no) (NN template)) (NN control) (PRN (-LRB- -LRB-) (NP (NN NC)) (-RRB- -RRB-))))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (HEADING (NP (NP (NML (NNP Western) (NN Blot)) (NN Analysis)) (PP (IN of) (NP (NN ITPR1) (NN Protein) (NNS Levels))) (PP-LOC (IN in) (NP (NP (NN EBV) (VBN Immortalized) (NNS Lymphoblasts)) (PP (IN from) (NP (NN AUS1) (NN Family) (NNS Members))))))) )
( (CAPTION (NP (NP (NNP Western) (NN blot)) (VP (VBN performed) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB examine) (NP (NP (NN ITPR1) (NNS levels)) (PP-LOC (IN in) (NP (NP (NN EBV) (VBN immortalized) (NNS lymphocytes)) (PP (PP (IN from) (NP (NP (ADJP (NN AUS1) (VBN affected)) (NN family) (NNS members)) (VP (VBG carrying) (NP (DT the) (NN ITPR1) (NN deletion))))) (CC and) (PP (IN from) (NP (NP (NP (DT an) (NN AUS1) (NN family) (NN member)) (PP (IN of) (NP (JJ unknown) (NN disease) (NN status)))) (SBAR (WHNP-1 (WP who)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ does) (RB not) (VP (VB carry) (NP (DT the) (NN deletion)))))))))))))))) (. .))) )
( (S (ADVP (RB Notably)) (NP-SBJ (NP (DT the) (NNS samples)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN ITPR1) (NN deletion)))))) (VP (VBP show) (NP (NP (DT a) (JJ dramatic) (NN decrease)) (PP (IN in) (NP (NN ITPR1) (NNS levels))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB demonstrate) (NP (JJ equal) (NN loading))))) (, ,) (S (S (NP-SBJ-1 (DT these) (NNS samples)) (VP (VBD were) (VP (VBN diluted) (NP-1 (-NONE- *)) (NP-EXT (NP (CD one)) (PP (IN in) (NP (CD five))))))) (, ,) (CC and) (S (NP-SBJ-2 (DT the) (NNP Western) (NN blot)) (VP (VBD was) (VP (VBN repeated) (NP-2 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT an) (NN antibody)) (PP (IN against) (NP (NN ACTB)))))))))) (. .)) )
( (HEADING (NP (NNS Footnotes))) )
( (S (NP-SBJ (NP (DT A) (JJ previous) (NN version)) (PP (IN of) (NP (DT this) (NN article)))) (VP (VBD appeared) (PP-MNR (IN as) (NP (DT an) (JJ Early) (JJ Online) (NN Release))) (PP-TMP (IN on) (NP (NP (NNP May) (CD 16)) (, ,) (NP-TMP (CD 2007)))) (PRN (-LRB- -LRB-) (NP (NN doi:10.1371/journal.pgen.0030108.eor)) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NN Author) (NNS contributions) (. .))) )
( (S (NP-SBJ (NNP EMCF) (, ,) (NNP JTR) (, ,) (CC and) (NNP ABS)) (VP (VBD conceived) (CC and) (VBD designed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP JvdL) (, ,) (NNP JC) (, ,) (NNP MAK) (, ,) (NNP LAH) (, ,) (NNP SS) (, ,) (NNP MRC) (, ,) (NNP HCF) (, ,) (NNP XL) (, ,) (NNP DH) (, ,) (NNP JSS) (, ,) (NNP IR) (, ,) (CC and) (NNP HC)) (VP (VBD performed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP JvdL) (, ,) (NNP JC) (, ,) (NNP MAK) (, ,) (NNP SS) (, ,) (NNP MRC) (, ,) (NNP KGH) (, ,) (NNP HCF) (, ,) (NNP JSS) (, ,) (NNP JTR) (, ,) (CC and) (NNP ABS)) (VP (VBD analyzed) (NP (DT the) (NNS data))) (. .)) )
( (S (NP-SBJ (NNP HH) (, ,) (NNP NWW) (, ,) (NNP PG) (, ,) (NNP JH) (, ,) (NNP ES) (, ,) (NNP RJMG) (, ,) (NNP SMF) (, ,) (NNP HC) (, ,) (CC and) (NNP ABS)) (VP (VBD contributed) (NP (NP (NNS reagents)) (HYPH /) (NP (NNS materials)) (HYPH /) (NP (NN analysis) (NNS tools)))) (. .)) )
( (S (NP-SBJ (NNP RJMG) (, ,) (NNP EMCF) (, ,) (CC and) (NNP ABS)) (VP (VBD wrote) (NP (DT the) (NN paper))) (. .)) )
( (HEADING (NP (NN Funding) (. .))) )
( (S (NP-SBJ-1 (DT This) (NN research)) (VP (VBD was) (VP (VBN funded) (NP-1 (-NONE- *)) (PP (IN in) (ADJP (JJ part))) (PP (IN by) (NP-LGS (NP (DT the) (JJ intramural) (NNS programs)) (PP (IN of) (NP (NP (NP (NP (DT the) (NNP National) (NNP Institute)) (PP (IN on) (NP (NNP Aging)))) (CC and) (NP (NP (NP (DT the) (NNP National) (NNP Institute)) (PP (IN on) (NP (NP (NNP Neurological) (NNPS Disorders)) (CC and) (NP (NNP Stroke))))) (-LRB- -LRB-) (NP (NN NINDS)))) (-RRB- -RRB-) (, ,) (NP (NP (DT both)) (PP (IN of) (NP (NP (NP (DT the) (NNP National) (NNPS Institutes)) (PP (IN of) (NP (NNP Health)))) (, ,) (NP-LOC (NP (NNP Department)) (PP (IN of) (NP (NP (NNP Health)) (CC and) (NP (NNP Human) (NNPS Services))))) (, ,) (NP-LOC (NP (NNP United) (NNP States)) (PP (IN of) (NP (NNP America))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NNP MAK)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT a) (NN NINDS) (JJ Competitive) (JJ Postdoctoral) (NN Fellowship))))) (. .)) )
( (S (NP-SBJ-1 (NNP HH)) (VP (VBZ is) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NML (NNP Medical) (NNP Research)) (NNP Council)) (, ,) (NP-LOC (NNP United) (NNP Kingdom)))))) (. .)) )
( (HEADING (NP (VBG Competing) (NNS interests) (. .))) )
( (S (NP-SBJ (DT The) (NNS authors)) (VP (VBP have) (VP (VBN declared) (SBAR (IN that) (S (NP-SBJ (DT no) (VBG competing) (NNS interests)) (VP (VBP exist)))))) (. .)) )
